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Stimulation of immunoglobulin E (IgE)-sensitized mast cells by multivalent 
antigen triggers a cascade of intracellular signaling events that results in granule 
exocytosis as a principal outcome. Granule exocytosis results in the release of 
histamine and other inflammatory mediators of the allergic response, and this process 
is mediated by Ca2+mobilization and activation of protein kinase C (PKC). MARCKS, 
a major PKC substrate, has been implicated in granule exocytosis. MARCKS has a 
polybasic effector domain (ED) that associates strongly with phosphatidylinositol 4,5- 
bisphosphate (PIP2) and other phosphoinositides at the inner leaflet of the plasma 
membrane. Using real-time fluorescence imaging, we observed antigen-stimulated 
oscillatory recruitment of EGFP-tagged PKCβΙ  to the plasma membrane in a process 
that is synchronous with the oscillatory displacement of mRFP-MARCKS-ED.  
 
 To investigate the role of PKC-mediated MARCKS phosphorylation in granule 
exocytosis, we created a MARCKS-ED mutant that cannot be phosphorylated. We 
observed that MARCKS-EDSA4 delays the onset of Ca2+ mobilization that is 
dependent on PIP2 hydrolysis to produce IP3 in response to antigen, but it does not 
inhibit store-operated Ca2+ entry (SOCE) activated by the SERCA pump inhibitor 
thapsigargin. Under these conditions, we found that granule exocytosis stimulated by 
 antigen as well as by thapsigargin is substantially inhibited. Our results provide strong 
evidence that phosphoinositides participate in the terminal steps of granule exocytosis, 
and they support the hypothesis that PKC normally regulates access of PIP2 to 
multiple proteins in both Ca2+ mobilization and granule exocytosis. 
 
 We also investigated the role of endogenous MARCKS and found that its 
knockdown resulted in reduced Ca2+ and degranulation responses to antigen, 
suggesting a positive regulatory role for endogenous MARCKS in these processes. 
These results contrast with the inhibition by MARCKS-ED SA4 in these processes, 
and they suggest that full length, endogenous MARCKS may be regulating multiple 
pathways. We hypothesize that endogenous MARCKS positively regulates antigen-
stimulated store-operated Ca2+ entry and granule exocytosis due to its association with 
Ca2+ bound calmodulin under stimulated conditions. These findings provide useful 
mechanistic insights into the roles of PKC, MARCKS and PIP2 in the intricate 
regulation of Ca2+ mobilization and granule exocytosis in stimulated mast cell 
signaling. 
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CHAPTER 1 
 
 
INTRODUCTION 
 
 
1.1 Mast cells: A brief overview 
 
Mast cells were discovered in the late 1800’s by Paul Ehrlich due to their strikingly 
characteristic staining of dense cytoplasmic granules containing vasoactive mediators including 
histamine (Prussin and Metcalfe, 2003). Mast cells are key players in allergy and asthma and are 
found underneath the epithelial layer, primarily lining the gut and the respiratory tract, and hence 
they form the first line of defense in the body. First exposure of the mucosal lining to any 
allergen/antigen results in production of IgE immunoglobulin from plasma cells (differentiated B 
cells) specific for that antigen. IgE binds to its high-affinity receptor FcεRI expressed on mast 
cells, and these mast cells are termed as being “sensitized” towards that antigen. Secondary 
exposure to antigen causes cross-linking of IgE-bound to its receptor on mast cells which 
releases allergic mediators in tissues and in the blood stream, causing smooth muscle 
contraction, vasodilation and increased vascular permeability (Metcalfe et al., 1997). This elicits 
the symptoms of allergy such as sneezing, itching etc. in an immediate response, followed by de 
novo synthesis and release of cytokines after several hours (Qiao et al., 2006).  
 
 
Rat basophilic leukemia cells (RBL-2H3 cells) are a cultured, mucosal mast cell line, often 
used as a model system for investigating IgE-mediated signaling cascade (Barsumian et al., 
1981). Stimulation of anti-DNP (2,4-dinitrophenyl) IgE-sensitized cells with DNP conjugated to 
 2 
 
bovine serum albumin (DNP-BSA) occurs as the result of cross linking of IgE leading to 
clustering of FcεRI. As depicted in Figure 1.1, receptor aggregation results in tyrosine 
phosphorylation of the receptor by the Src family kinase, Lyn, which leads to the recruitment of 
Syk kinase from the cytosol causing phosphorylation of downstream targets. A key signaling 
event is activation of phospholipase Cγ (PLCγ), which hydrolyzes membrane phospholipid 
phosphatidylinositol 4,5-bisphosphate (PIP2) to produce two important second messengers: 
inositol 1,4,5-trisphosphate (IP3) and diacyl 2,3-glyecrol (DAG). IP3 binds to its receptors in the 
endoplasmic reticulum causing release of Ca2+ from the ER stores. DAG together with Ca2+ 
causes activation of multiple isoforms of protein kinase C (PKC). Elevation of cytosolic Ca2+ 
and PKC activation synergistically stimulate granule exocytosis (also referred to as 
degranulation) in mast cells, causing the release of preformed allergic mediators and also causing 
cell ruffling and spreading (Blott and Griffiths, 2002; Sagi-Eisenberg and Pecht, 1984). Release 
of histamines and serotonin causes minor allergy symptoms, however, in some extreme cases, 
these symptoms can escalate to more serious medical conditions like anaphylaxis and asthma. 
Currently available drugs are only partially effective in the treatment of these life threatening 
conditions. Understanding the intricate regulatory mechanisms of exocytosis in mast cells will 
provide useful insight for the development of novel therapeutics. 
 
 
1.2 Ca2+: Critical requirement for granule exocytosis 
 
Cytosolic Ca2+ elevation is a universal requirement for many cellular mechanisms in both 
excitable and non-excitable cells. A primary requirement for exocytosis in mast cells is elevated 
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Figure 1.1: IgE-mediated signaling cascade within an antigen-stimulated mast cell 
resulting in degranulation. 
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 cytosolic Ca2+, which facilitates the fusion of secretory vesicles with the plasma membrane 
(Berridge, 2004; Clapham, 2007). Receptor stimulation causes Ca2+ elevation in the form of 
puffs (localized increase), waves or oscillations (Berridge, 2006). Ca2+ elevation in mammalian 
cells is a biphasic process: IP3-mediated Ca2+ release from endoplasmic reticulum (ER) stores 
causes the initial rise in cytosolic Ca2+ concentration; this is followed by sustained transient 
elevations (oscillations) dependent on extracellular Ca2+ (Narenjkar et al., 1999; Putney and 
Bird, 1993). Stromal interaction molecule 1 (STIM1), an EF-hand domain transmembrane 
protein present in the ER senses depletion of Ca2+ from the ER and redistributes to junctions with 
the plasma membrane where it couples with the Ca2+ channel protein, Orai1, leading to influx of 
extracellular Ca2+ into the cytosol (Feske et al., 2006; Liou et al., 2005; Zhang and McCloskey, 
1995).  
 
The amplitude and frequency of Ca2+ oscillations varies from cell to cell, and it remains 
intriguing why Ca2+ elevation follows such a rhythmic pattern. One of the most widely accepted 
speculations in the literature is that oscillatory elevation of Ca2+ is required to selectively 
regulate a variety of downstream effectors, and each oscillatory peak encodes signals for 
different signaling pathways (Dolmetsch et al., 1998). 
 
 
 Previous studies have indicated a temporal correlation between the peaks of stimulated 
Ca2+ oscillations with the fusion of secretory granules with the plasma membrane in RBL cells 
(Kim et al., 1997). However, it should be noted that thapsigargin, a pharmacologic agent which 
prevents the re-uptake of Ca2+ into the ER causes a sustained, non-oscillatory elevation of Ca2+ 
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in the cytosol and also induces significant granule exocytosis in adherent mast cells (Wolfe et al., 
1996). The mechanism by which Ca2+ participates in exocytosis is still unclear. Ca2+ binding to 
PIPs has been shown to be involved in facilitating the insertion of synaptotagmins bound to 
secretory vesicles into the plasma membrane prior to fusion (Bai et al., 2004).  
 
1.3 Protein Kinase C: Regulator of degranulation in mast cells 
  
 
 Protein Kinase C was discovered in late 1970’s by Nishizuka and colleagues as a target 
for phorbol esters, which brought PKC to the forefront of cancer research (Nishizuka et al., 1978; 
Takai et al., 1979). Phorbol esters are structural analogs of diacylglycerol (DAG), which is a 
physiological activator of PKC. DAG is readily metabolized in cells resulting in transient PKC 
activation, however, phorbol esters cannot be metabolized by the cells, causing sustained PKC 
activation and resulting in tumor promotion due to increased proliferative activity of cells. In 
mast cells, previous studies have shown evidence for the involvement of PKC in granule 
exocytosis due to the synergistic action of phorbol myristoyl acetate (PMA) and Ca2+ ionophore 
to cause stimulated degranulation (Sagi-Eisenber and Pecht, 1984). 
 
 PKC is a family of Ser/Thr kinases, all of which contain a regulatory region at the N-
terminus and a catalytic kinase core at the C-terminus (Steinberg, 2008). The regulatory region is 
composed of a Cys-rich C1 domain and/or a C2 domain which is known to bind Ca2+ ions in 
conjunction with negatively charged phospholipids. It has also been reported recently that 
conventional PKCs bind directly to PIP2 through their C2 domain (Corbalan-Garcia et al., 2007). 
The kinase core has an auto inhibitory motif occupying the active site in the inactive state of 
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PKC, and, upon PKC activation, conformational changes cause release of this auto inhibitory 
motif, thus exposing the active site of PKC as shown in Figure 1.2. 
 
 All PKC isoforms have been subdivided into three categories based on their activation 
requirements. The conventional class of PKCs (α, β and γ) has C1 and C2 domains which bind 
DAG and Ca2+, respectively, for activation. The PKCβ isoform has two splice variants, βI and 
βII, which are generated by alternative splicing of C-terminal exons (V5 domain) (Ono et al., 
1987).  The novel class of PKCs (δ, ε, η and θ) requires only DAG for activation as they lack a 
C2 domain for Ca2+ binding. The atypical PKC class (ζ and λ) does not require either DAG or 
Ca2+ for their activity, but instead it is activated by ceramides by an unknown mechanism. 
Although binding of Ca2+ enhances the capacity of conventional PKC isoforms to translocate to 
the membrane and bind to DAG, this is not essential, as shown by the capacity of phorbol esters 
to cause translocation of conventional PKC isoforms independently of Ca2+ elevation (Oancea 
and Meyer, 1998). 
 
 Apart from Ca2+ binding, conventional PKC isoforms also require sustained DAG 
production for their translocation to the plasma membrane. DAG, a product of PIP2 metabolism, 
shows sustained elevation in stimulated mast cells (Kennerly et al., 1979). Mast cells also 
express various isoforms of DAG kinases (DGK) which phosphorylate DAG, resulting in 
phosphatidic acid production. Koretzky and colleagues have demonstrated that DGKζ- deficient 
bone marrow-derived mast cells exhibit significantly decreased degranulation, Ca2+ response, 
PLCγ activity, as well as decreased PKCβII membrane recruitement (Olenchock et al., 2006). 
Based on their results, one can speculate that DGKs play a significant role in the dissociation of 
PKC from the membrane or that phosphatidic acid is important for PLCγ activation. RBL-2H3 
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Figure 1.2: Schematic diagram showing conventional PKC isoforms in their 
inactive (left) and active (right) states. In the resting state of cells, the active site of 
PKC is sequestered by an auto inhibitory sequence (pink). Upon Ca2+ (black) 
binding, PKC translocates to the plasma membrane, where it binds to DAG 
(orange) via its C1A and C1B domains, resulting in the exposure of the active site 
of PKC in the kinase domain (green). 
 
 8 
 
 cells express both conventional and novel isoforms (α,β,δ,ε and ζ), and studies have shown that 
their over expression results in increased proliferative response and enhancement or inhibition of 
the production of certain cytokines (Chang et al., 1997). Previous studies have shown that over 
expression of the PKCβ isoform significantly increases secretion, phospholipase A2 activation, 
and production of IL-6. Reconstitution studies with PKC isoforms (Ozawa et al., 1993a; Ozawa 
et al., 1993b), together with genetic knockout have established a positive regulatory role of the 
PKCβ isoform in mast cell stimulation-secretion coupling (Nechushtan et al., 2000). 
Interestingly, knockout of PKCδ results in an enhancement in mast cells degranulation, 
suggesting that this isoform plays a negative regulatory role in granule exocytosis (Leitges et al., 
2002). However, the mechanism by which these isoforms participate in regulating the exocytotic 
machinery is not well understood. However, it is well established that PKC regulates exocytosis 
at a terminal step, as demonstrated by the capacity of PKC inhibitors to inhibit degranulation in 
mast cells with equal effectiveness when stimulated by antigen or Ca2+ ionophore (Wolfe et al., 
1996).  
 
 Recent studies with GFP-tagged PKCs have demonstrated the spatio-temporal dynamics 
of PKC translocation in single, living cells upon stimulation. Meyer and colleagues have shown 
transient oscillatory translocation of PKCγ isoform in RBL cells upon receptor stimulation 
(Oancea and Meyer, 1998). 
 
1.4 MARCKS and its interaction with phosphoinositides 
 
 Myristoylated alanine-rich C-kinase substrate (MARCKS) is a major, ubiquitous 
substrate of PKC. It was discovered in brain synaptosomes in 1982 (Wu et al., 1982)  and plays 
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multiple roles in regulating cellular signaling processes such as membrane ruffling and cell 
spreading. Interestingly, MARCKS expression levels have been found to be significantly 
reduced in cancerous cells and over-expression of MARCKS can suppress cancer cell 
proliferation (Manenti et al., 1998). Studies have shown that knockout of MARCKS results in 
abnormal brain development and is embryonically lethal in mice (Stumpo et al., 1995). It has 
also been reported in the literature that PKC-dependent phosphorylation of MARCKS is 
important for brain and retina development in mice. Blackshear and colleagues reported that the 
phosphomimetic mutant of MARCKS can rescue these defects, but these mice did not survive 
after few hours (Scarlett and Blackshear, 2003). The capacity of a 24 amino acid peptide 
identical to the N-terminus of MARCKS (MANS peptide) to inhibit mucin secretion from human 
airway epithelial cells in-vitro and in mice has made it an attractive target in therapeutics (Singer 
et al., 2004). PKC-dependent MARCKS phosphorylation has also been shown to be important in 
regulating granule exocytosis in chromaffin cells (Elzagallaai et al., 2000), however, the 
mechanism is still not understood. 
 
 
MARCKS is 309 amino acids long and has a myristoyl moiety at the N-terminus, as 
shown in Figure 1.3. Many of the functional interactions of MARCKS, including PKC 
phosphorylation, phospholipid binding, F-actin cross-linking, and calmodulin binding are due to 
the presence of a highly polybasic 25 amino acid long sequence of charge +13 referred to as 
effector domain (MARCKS-ED) (McLaughlin and Murray, 2005). This effector domain has four 
Ser residues, three of which are phosphorylated by PKC, the phosphorylation of fourth Ser 
residue is controversial. In resting cells, MARCKS is strongly localized to the membrane due to 
myristoylation as well as to electrostatic interactions of its effector domain with anionic
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Figure 1.3: Schematic diagram depicting the association of MARCKS with the 
plasma membrane through anchorage of its myristoyl moiety and through 
electrostatic interactions of the effector domain with negatively charged 
phospholipids. 
 
 11 
 
phospholipids (Swierczynski and Blackshear, 1996). As depicted in Figure 1.4, PKC activation 
in stimulated cells results in phosphorylation of Ser residues in the MARCKS effector domain, 
thereby disrupting its electrostatic interaction with the membrane and causing its translocation to 
the cytosol. MARCKS is dephosphorylated by protein phosphatase I, protein phosphatase 2A or 
calcineurin, casuing it to reassociate with the plasma membrane (Seki et al., 1995).  
 
 
 There is growing evidence in the literature that negatively charged phosphatidylinositol 
lipids, specifically, PIP2 and PIP3, are sequestered in the plasma membrane by proteins that have 
clusters of positively charged amino acids. Even though PIP2 comprises only 1% of the total 
phospholipid content in the plasma membrane, it plays multiple, critical roles in signaling 
pathways such as endocytosis, exocytosis, phagocytosis and membrane ruffling (Di Paolo and 
De Camilli, 2006). McLaughlin and colleagues have demonstrated that MARCKS-ED shows 
tight binding to lipid bilayers that incorporate PIPs (Wang et al., 2001). Dissociation of 
MARCKS from the plasma membrane due to PIP2 hydrolysis and inhibition of PIP synthesis has 
demonstrated that PIPs are primarily responsible for the association of MARCKS with the 
plasma membrane, as shown by Meyer and colleagues (Heo et al., 2006). As PIP2 has a net 
charge of -4 at neutral pH (McLaughlin et al., 2002), a single MARCKS-ED can electrostatically 
sequester three molecules of PIP2. The capacity of MARCKS to regulate the availability of 
phosphoinositides reversibly under physiological conditions makes it a suitable candidate for 
regulating PIP-dependent processes upon receptor stimulation.  
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Figure 1.4: Stimulation of cells results in translocation and 
activation of PKC, causing phosphorylation of MARCKS-ED 
and consequent dissociation from the plasma membrane.  
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1.5 Granule exocytosis in mast cells 
 
 
 Mast cell secretory granules store pre-formed allergic mediators including histamine and 
serotonin as well as certain enzymes such as β-hexosaminidase, all of which are secreted upon 
stimulation of these cells. The terminal steps resulting in granule exocytosis in mast cells are a 
complex, well-coordinated process which is still not fully understood. This involves 
translocation of secretory vesicles to the plasma membrane, docking of secretory vesicles, 
followed by fusion and release of secretory content into the extracellular environment (Martin, 
2003).  
 
 Mast cells express the essential components of exocytotic machinery, namely, 
synaptotagmins and soluble N-ethylmaleimide sensitive fusion (NSF) attachment receptor 
proteins (SNAREs) which tightly regulate the exocytosis process with the help of adaptor 
proteins and Ca2+. Similar to synaptic vesicle exocytosis (Rizo and Rosenmund, 2008), mast cell 
exocytosis also has a critical requirement for an interaction between vesicle or v-SNAREs and 
target or t-SNAREs to form a trans-SNARE complex resulting in membrane fusion prior to 
release of chemical mediators. A variety of SNARE proteins are expressed in RBL cells, 
including syntaxin 4, SNAP 23 (non-neuronal isoform of SNAP 25), VAMP-7 and VAMP-8 that 
have been shown to be essential for mast cell degranulation (Paumet et al., 2000; Sander et al., 
2008).  Due to the sensitivity of granule exocytosis to PKC inhibitors, a lot of work has been 
done to understand the roles of PKC substrates in the fusion process including SNARES as 
shown by in-vitro studies. A survey of literature indicates that other PKC substrates may also 
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play critical roles in degranulation. Munc18-1, a prominent PKC substrate, has turned out to be a 
very promising candidate due to its capacity to bind to syntaxin-1, which is a t-SNARE and 
possesses a juxtamembrane stretch of basic amino acids capable of interacting with acidic 
phospholipids (Burgoyne and Morgan, 2003). Interestingly, disruption of the Munc 18-1 - 
syntaxin-1 interaction can cause inhibition and delay of granule fusion events in PC12 cells 
(Barclay, 2008).  
 
 Recent advances in imaging and electrochemical methods such as patch-clamp 
capacitance measurements have enabled significant mechanistic insights into granule exocytosis 
at a single cell level. The ability to fluorescently label secretory lysosomes has made it possible 
to visualize individual secretory vesicles. One of the recently developed approaches to monitor 
exocytosis events at high spatial and temporal resolution utilizes fluorescein isothiocyanate-
conjugated dextran (FITC-dextran), which is taken up by fluid phase pinocytosis into secretory 
lysosomes. Mast cell granules, which originate from secretory lysosomes (Dragonetti et al., 
2000), have acidic pH due to which FITC fluorescence remains quenched, however, upon fusion 
with the plasma membrane, FITC fluorescence can be visually monitored due to fluorescence 
dequenching upon neutralization. Single cell techniques employed simultaneously with other 
exocytosis quantification methodologies will certainly help gain more clear mechanistic insights 
into the intricate regulation of exocytotic machinery.  
 
 
1.6  Current studies  
 
 This dissertation describes the dynamics of PKCβ, MARCKS and phosphoinositides in 
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regulating stimulated granule exocytosis in mast cells. The data presented in Chapter 2 shows the 
dynamic interaction of PKCβI-EGFP with the plasma membrane upon antigen stimulation, 
which correlates with oscillatory elevations of Ca2+ in the cytoplasm. Furthermore, we show that 
mRFP-MARCKS-ED association with the plasma membrane oscillates in synchrony with the 
association of PKC with the plasma membrane, which in turn is synchronized to Ca2+ 
oscillations. To investigate the role of PKC-dependent exposure of PIPs under stimulated 
conditions, we created a mutant of mRFP-MARCKS-ED (SA4) which cannot be phosphorylated 
by PKC. The capacity of this probe to alter IP3-dependent Ca2+ release from stores provides 
strong evidence for its capacity to sequester phosphoinositides. To investigate the role of PKC 
and PIPs in granule exocytosis, we compared the effect of mRFP-MARCKS-ED and mRFP-
MARCKS-ED SA4 on stimulated granule exocytosis. We observe substantial inhibition of both 
antigen and thapsigargin-stimulated granule exocytosis by the latter but not the former construct, 
suggesting that events downstream of Ca2+ mobilization in granule exocytosis depend on 
sequestration of PIPs in a non-reversible manner.  
 
 In Chapter 3, we perform knockdown of full length endogenous MARCKS in RBL cells 
and characterize the effects of this perturbation on stimulated Ca2+ mobilization and 
degranulation. Our results indicate that full length, endogenous MARCKS positively regulates 
these processes, and we hypothesize that its association with Ca2+/calmodulin under stimulated 
conditions inhibits the interaction of Ca2+/calmodulin with STIM1, hence positively regulating 
SOCE and granule exocytosis. 
 
 In Appendix 1, we characterize a broad series of bifunctional sulfonated DNP-poly(2-
methoxystyrene) polymers and a biodegradable polymer for their potential to serve as leads for 
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allergy therapeutics.  
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CHAPTER 2 
SEQUESTRATION OF PHOSPHOINOSITIDES BY MUTATED MARCKS EFFECTOR 
DOMAIN INHIBITS STIMULATED CA2+ MOBILIZATION AND DEGRANULATION IN 
MAST CELLS 
2.1  Abstract  
 
 Protein kinase C β (PKCβ) participates in antigen-stimulated mast cell degranulation 
mediated by the high affinity receptor for IgE, FcεRI, but the molecular basis is unclear. We 
investigated the hypothesis that the polybasic effector domain (ED) of the abundant intracellular 
substrate for PKC known as MARCKS sequesters phosphoinositides at the inner leaflet of the 
plasma membrane until MARCKS dissociates after phosphorylation by activated PKC. Real time 
fluorescence imaging confirms synchronization between stimulated oscillations of intracellular 
Ca2+ concentrations and oscillatory association of PKCβ-EGFP with the plasma membrane. 
Similarly, MARCKS-ED tagged with mRFP undergoes antigen-stimulated oscillatory 
dissociation and rebinding to the plasma membrane with a time course that is synchronized with 
reversible plasma membrane association of PKCβ. We find that MARCKS-ED dissociation is 
prevented by mutation of four serine residues that are potential sites of phosphorylation by PKC. 
Cells expressing this mutated MARCKS-ED S4A show delayed onset of antigen-stimulated Ca2+ 
mobilization and substantial inhibition of granule exocytosis. Stimulation of degranulation by 
thapsigargin, which bypasses inositol 1,4,5-trisphosphate production, is also substantially 
reduced in the presence of MARCKS-ED S4A, but store-operated Ca2+ entry is not inhibited. 
These results show the capacity of MARCKS-ED to regulate granule exocytosis in a PKC-
dependent manner, consistent with regulated sequestration of phosphoinositides that mediate 
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granule fusion at the plasma membrane. 
 
2.2  Introduction 
 
 Granule exocytosis in mast cells is stimulated by antigen-mediated crosslinking of IgE 
bound to high affinity receptors (FcεRI), and much is known about this physiologically 
important process in allergic and inflammatory responses (Blank and Rivera, 2004; Gilfillan and 
Tkaczyk, 2006). As for many other receptor-activated exocytotic responses in other cell types, 
critical roles for Ca2+ mobilization and PKC activation are well established (Ma and Beaven, 
2009; Nechushtan et al., 2000). Mast cells do not exhibit voltage-gated Ca2+ influx, but it is 
known that store operated Ca2+ entry participates in IgE receptor-stimulated degranulation. 
Previous studies revealed contributions both from CRAC channels, Orai1/CRACM1 (Vig et al., 
2008) and from TRPC channels (Ma et al., 2008; Suzuki et al., 2010). As for exocytosis in other 
cell types, mast cell granules, which are secretory lysosomes (Dragonetti et al., 2000; Xu et al., 
1998), depend on elevated intracellular [Ca2+] for fusion with the plasma membrane, and this 
requirement has been suggested to be due to triggering of SNARE-mediated fusion by granule-
associated Ca2+/synaptotagmin complexes bound to polyphosphoinositides at the inner leaflet of 
the plasma membrane (Dai et al., 2007; Paddock et al., 2008). The involvement of 
phosphatidylinositol 4,5- bisphosphate (PIP2) in facilitating the membrane fusion triggered by 
synaptotagmin implicates  this phospholipid as a key player in Ca2+-dependent exocytosis (Bai et 
al., 2004). 
 
The mechanism of PKC participation in mast cell granule exocytosis is less clear. PKC 
comprises a family of at least 10 different Ser/Thr kinases that play multiple roles in cell 
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signaling (Newton, 2010; Nishizuka, 1995). These isoforms of PKC have been classified into 
three categories based on structural and activation requirements: conventional and novel 
subfamilies are activated by diacylglycerol binding to a C1 domain, and conventional isoforms 
also require Ca2+ binding to a C2 domain. These subfamilies are activated by phorbol esters, 
which are structural mimics of diacylglycerol, providing early evidence for participation of PKC 
activity in mast cell degranulation (Sagi-Eisenberg et al., 1985). Reconstitution studies with PKC 
isoforms in permeabilized RBL mast cells yielded the first direct evidence for positive roles for 
PKCβ and δ in IgE receptor-stimulated degranulation (Ozawa et al., 1993a). Genetic knockout of 
PKCβI revealed that this isotype is important in mast cell degranulation (Nechushtan et al., 
2000). Despite these advances, the mechanism for PKC activity in this and other exocytotic cell 
processes is not well understood.  
 
 A prominent substrate for PKC isoforms is the myristoylated alanine-rich C-kinase 
substrate commonly called MARCKS (Aderem, 1992; Blackshear, 1993). MARCKS binds 
tightly to membranes containing negatively charged phospholipids via a 25 amino acid sequence 
that contains 13 basic amino acids and is known as its effector domain (ED) (Wang et al., 2001). 
Meyer and colleagues showed that this sequence could be displaced from the plasma membrane 
by depletion of polyphosphoinositides, providing evidence that these negatively charged 
phospholipids are the principal means by which this protein anchors to the plasma membrane 
(Heo et al., 2006). This ED sequence contains four serine residues, three of which are 
phosphorylated by activated PKC to cause its dissociation from the plasma membrane (Graff et 
al., 1989a; Graff et al., 1989b). MARCKS has been shown to participate in granule exocytosis in 
platelets and chromaffin cells (Trifaro et al., 2008), but the mechanism is unknown.  
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Although PIP2 constitutes only ~1% of the phospholipids in the plasma membrane, it 
plays a key role in regulating a large number of cellular processes, including clathrin-mediated 
endocytosis, activation of ion channels, actin polymerization, phagocytosis, and synaptic vesicle 
exocytosis (Di Paolo and De Camilli, 2006). In mast cells, antigen-stimulated activation of 
phospholipase Cγ (PLCγ) results in hydrolysis of PIP2 to form inositol 1,4,5-trisphosphate (IP3) 
and diacylglycerol; thus, PIP2 is an important participant in Ca2+ mobilization and activation of 
PKCs. However, the lack of specific inhibitors of PIP2 synthesis has made it difficult to probe 
the mechanisms by which PIP2 regulates multiple, diverse functions in mammalian cells. We 
hypothesize that one of the key roles of PIP2 -- wherein it interacts with synaptotagmins to 
facilitate granule exocytosis -- is controlled by PKC activity: PKC regulates the availability of 
PIP2 because PKC phosphorylation causes MARCKS dissociation, thereby exposing PIP2 to 
interact with other proteins. In the present study, we utilize the high avidity of the MARCKS-ED 
peptide and introduce mutations to prevent its dissociation from the plasma membrane by 
activated PKC. We demonstrate that expression of this mutated protein (MARCKS-ED S4A) 
effectively delays antigen-stimulated Ca2+ mobilization that is dependent on PIP2-mediated IP3 
production.  Furthermore, MARCKS-ED S4A inhibits granule exocytosis by antigen as well as 
by thapsigargin, which bypasses the need for IP3 production in this process. These results 
provide strong evidence that this mutated MARCKS-ED construct is an effective inhibitor of 
PIP2-dependent processes, and thereby it serves as a useful tool for investigating these processes. 
 
2.3  Experimental 
 
cDNA plasmids 
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 PKCβI-EGFP was from Clontech (Palo Alto, CA). mRFP-MARCKS-ED was made from 
YFP-MARCKS-ED by exchanging YFP for mRFP by using the Nhe I and Hind III restriction 
sites. To generate mRFP-MARCKS-ED SA4, mutation of serines 159, 163, 167 and 170 
(MARCKS full-length sequence numbers (Stumpo et al., 1989)) to alanines were performed by 
using QuickChange Site-Directed Mutagenesis Kit from Stratagene (La Jolla, CA) as previously 
described (Smith et al., 2010). Mutations were confirmed by DNA sequence analysis. 
MARCKS-ED and MARCKS-ED SA4 were generated by removing mRFP from the respective 
fluorescent constructs. The PM-EGFP construct was prepared as previously described (Pyenta et 
al., 2001)  
 
Cell Culture and Transient/Stable Transfection 
 
 RBL-2H3 cells were maintained as monolayers in minimal essential medium (MEM) 
containing 20% fetal bovine serum and 10µg/mL gentamicin sulfate. Cells were harvested using 
trypsin-EDTA (Invitrogen) and transiently transfected using electroporation as previously 
described (Cohen et al., 2009). Electroporated cells were plated into MatTek coverslip wells 
(Dover, MA) in full medium and sensitized with mouse monoclonal anti-DNP IgE (0.5 
µg/ml;(Posner et al., 1992)) during overnight culture. All experiments were done 20-24 h post 
transfection. For the generation of stable RBL cell lines expressing mRFP-MARCKS-ED SA4, 
transfected cells were selected in MEM containing 600 µg/ml G418 (Gibco, Invitrogen Corp., 
Carlsbad, CA). Cells positive for mRFP-MARCKS-ED SA4 were identified by mRFP 
fluorescence. Clones of cells expressing mRFP-MARCKS-ED SA4 were picked using calcium 
alginate fiber tipped wood applicator swabs (Fisher HealthCare, TX). One mutant clone with a 
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relatively low expression level and two mutant clones expressing relatively high levels of mRFP-
MARCKS-ED SA4 were produced and characterized. 
 
Live cell imaging and analysis 
 
 Prior to imaging, cells were rinsed with buffered saline solution (BSS: 20 mM HEPES, 
135 mM NaCl, 1.8 mM CaCl2, 1 mM MgCl2, 5mM KCl, 5.6 mM glucose, 1 mg/ml BSA, pH 
7.4), then imaged using a Leica TCS SP2 upright confocal microscope with an APO 63x dipping 
objective. Images were collected every 4 s for 1-2 min before stimulation, followed by 5-10 min 
of image acquisition post-stimulation using DNP-BSA (0.2 µg/ml – 1 µg/ml) or thapsigargin 
(0.15 µM). All live cell imaging was carried out between 25-37˚C as specified. For image 
analysis, a small cytoplasmic region of interest was chosen in each cell to monitor the fractional 
cytoplasmic fluorescence intensity changes with time using ImageJ (NIH). 
 
Intracellular [Ca2+] measurement of adherent cells 
 
 Overnight-plated and IgE-sensitized cells in MatTek dishes were loaded with Fluo-4 AM 
(Invitrogen) or Fura Red AM (Invitrogen) at 1 µg/mL in BSS buffer containing 0.5 mM 
sulfinpyrazone (Sigma) for 10 min at 37˚C. Cells were then washed 3 times in 
BSS/sulfinpyrazone. Fields of cells were selected to contain both transfected and untransfected 
cells and monitored as previously described (Calloway et al., 2009). For measurement of Ca2+ 
release from endoplasmic reticulum stores alone, BSS without Ca2+ was used while imaging, and 
2 mM CaCl2 was added subsequently to observe store-operated Ca2+ entry. 
 
 27 
 
Intracellular [Ca2+] measurements of suspended cells 
 
 Cells suspended in BSS were sensitized with anti-DNP IgE and loaded with indo-1 AM 
(Invitrogen). Time-based acquisition of cytoplasmic [Ca2+] was monitored in an SLM 8100C 
fluorimeter, and cells were stimulated with 0.2 µg/ml DNP-BSA or 0.15 µM thapsigargin. 
Stimulated [Ca2+] responses were normalized by dividing by (the total indo-1 fluorescence 
following cell lysis by addition of 0.1% Triton X-100) minus (the fluorescence in the presence of 
excess EDTA) (Vasudevan et al., 2009).  
 
Granule exocytosis monitored by FITC-dextran release 
 
 Cells were transfected with mRFP-MARCKS-ED SA4 and cultured as described above. 
They were further loaded overnight with 1 mg/ml FITC-dextran (10,000 MW from Sigma-
Aldrich) and 0.2 mM 5-hydroxytryptamine (Sigma-Aldrich) as described in Cohen et al. 
(submitted). Cells were washed 3 times with BSS, and live cell imaging was performed at 37˚C 
on a Zeiss 710 confocal microscope with maximum pinhole size to visualize degranulation 
events throughout the entire cell depth. Cells were stimulated with 0.4 µg/ml DNP-BSA, and 
detection of degranulation events as fluorescence bursts were recorded from movies similar to 
that in Supplemental Movie M2.4. Time of onset of degranulation was determined as the average 
time for the first five exocytosis events. 
 
Granule exocytosis monitored by anti-CD63 labeling 
 
 Cells were co-transfected with unlabeled MARCKS-ED SA4 and palmitoylated, 
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myristoylated EGFP (PM-EGFP) or transfected with PM-EGFP alone (control) by 
electroporation, then cultured in full media as described above. Cells were sensitized with anti-
DNP IgE (0.5 µg/ml) overnight and then stimulated with 0.4 µg/ml of DNP-BSA or 1 µM 
thapsigargin in the presence of 1 µM cytochalasin D (Sigma-Aldrich) for 10 minutes at 37˚ C, 
then fixed with 4% paraformaldehyde and 0.1% glutaraldehyde for 15 minutes at room 
temperature. Fixed cells were labeled with 5 µg/ml anti-CD63 mouse antibody (AD1; 
PharMingen) for 1 h at room temperature, followed by 10 µg/ml fluorescent secondary antibody 
(Alexa-555 goat anti-mouse IgGγ1; Invitrogen) for 1 h at room temperature. Imaging of fixed 
samples was carried out at the equatorial plane of the cells using a Leica confocal TCS SP2 
microscope as described above. Analysis of images was done by first generating a plasma 
membrane mask by thresh holding the PM-EGFP image in Matlab (Mathworks; (Calloway et al., 
2009)). Fluorescence of Alexa-555 goat anti-mouse IgGγ1 was determined by integrating the 
fluorescence intensity of all pixels in the plasma membrane mask for each cell. Control labeling 
was performed using non-specific primary mouse IgG antibody under the same conditions as for 
AD1 labeling. 
 
2.4  Results 
 
 To characterize the spatial and temporal changes of PKCβI in antigen-stimulated RBL-
2H3 cells, we performed real time fluorescence imaging of PKCβI-EGFP in transiently 
transfected cells. In unstimulated cells, PKCβI-EGFP is distributed homogeneously in the 
cytoplasm. Upon antigen stimulation, we observe a rapid translocation of PKCβI-EGFP to the 
plasma membrane in 70-80% of transfected cells with variable onset times, and this is followed 
by periodic dissociation and re-association with the plasma membrane. Figure 2.1 and the 
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supplemental movie M2.1 show this for PKCβI-EGFP at 37oC; the accompanying plot quantifies 
changes in cytoplasmic fluorescence for a single representative cell. Antigen stimulation of RBL 
cells at 25oC also causes PKCβI-EGFP association and dissociation with the plasma membrane 
as shown in Figure 2.2A. The periodicity of these oscillations in multiple cells is in the range of 
40-60 s, similar to that at 37°C. The average lag time for the onset of this response at 37oC is 50 
s (SEM = + 4.2 s; n = 28), and this lag time is 10 s longer at 25oC (40 + 3.3 s; n=43). 
Thapsigargin, an inhibitor of the sarcoplasmic/endoplasmic reticulum ATPase, also activates 
PKCβI-EGFP recruitment to the plasma membrane, but this occurs more slowly and without the 
oscillatory association and dissociation that is seen with antigen (Figure 2.2B). This recruitment 
may be due to diacylglycerol production stimulated by thapsigargin in a pathway that utilizes 
activation of phospholipase D (Peng and Beaven, 2005). 
 
 We compared the time course of antigen-stimulated oscillations in Ca2+ concentrations to 
the periodic translocation of PKCβI-EGFP to the plasma membrane by simultaneously imaging 
PKCβI-EGFP and [Ca2+] using the indicator Fura Red, which exhibits a decrease in fluorescence 
when [Ca2+]  is elevated. As represented in Figure 1D, we observe a strong temporal correlation 
between the time course of [Ca2+] oscillatory increases in the cytoplasm and that for PKCβI-
EGFP oscillatory translocation to the plasma membrane. Recruitment of PKCβI-EGFP to the 
plasma membrane follows the onset of the cytoplasmic [Ca2+] increase by several seconds for 
each of the [Ca2+] oscillations, and this is evident in Figure 2.3 as a delay in the depletion of 
cytoplasmic PKCβI-EGFP relative to the increase in cytoplasmic [Ca2+] at each oscillation. 
 
To monitor the activity of PKC at the plasma membrane, we co-expressed MARCKS-ED 
 30 
 
 
 
Figure 2.1: Dynamics of stimulated PKCβI-EGFP redistributions in IgE-sensitized 
RBL cells. Time course of PKCβI-EGFP redistributions (green) in cells upon 
stimulation with antigen at 37oC (still frames from Supplemental Movie M2.1). 
Times in images indicate intervals after antigen addition. Plot shows relative 
cytoplasmic fluorescence in the region of interest marked in a representative 
individual cell. Bars, 10 μm.  
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Figure 2.2: (A) Time course of PKCβI-EGFP 
recruitment to the plasma membrane upon antigen 
stimulation at 25oC monitored as depletion of 
cytoplasmic fluorescence in a single representative 
cell. (B) Time course of PKCβI-EGFP recruitment to 
the plasma membrane upon stimulation with 
thapsigargin at 37oC monitored as depletion of 
cytoplasmic fluorescence for an average of 6 cells.  
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Figure 2.3: Time courses of PKCβI-EGFP recruitment to 
the plasma membrane monitored as depletion of 
cytoplasmic fluorescence (blue) and cytoplasmic [Ca2+] 
changes monitored by Fura Red (red) in a single 
representative cell stimulated with antigen at 37oC.  
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 labeled with mRFP. In unstimulated RBL cells, mRFP-MARCKS-ED is concentrated at the 
plasma membrane as shown in Figure 2.4, upper panel. Upon stimulation with antigen, 
dissociation of mRFP-MARCKS-ED from the plasma membrane correlates with recruitment of 
PKCβI-EGFP (Figure 2.4, lower panel; in Supplemental Movies M2.2a and M2.2b). As shown 
in Figure 2.5, there is a strong temporal correlation between the association of PKCβI-EGFP and 
the dissociation of mRFP-MARCKS-ED from the plasma membrane, suggesting that stimulated 
PKC recruitment and activation results in periodic phosphorylation and dissociation of 
MARCKS-ED. We observed similar temporal correlation between MARCKS-ED PKCβI 
oscillations in 81% of cells co-expressing these two constructs (n = 21).  
 
 To evaluate the roles of phosphoinositides in stimulated Ca2+ mobilization and 
degranulation, we developed a probe to inhibit their accessibility under conditions where they are 
normally available.  (Heo et al., 2006) showed that recruitment of inositol 5’-phosphatase to the 
plasma membrane to hydrolyze PIP2, together with pharmacologic inhibition of PI3-and PI4-
kinases, causes MARCKS-ED to dissociate from the plasma membrane. We reasoned that if we 
eliminated the capacity of PKC to displace MARCKS-ED from the plasma membrane under 
stimulating conditions, tight binding of MARCKS-ED to phosphoinositides would prevent 
access of proteins that utilize PIP2 for their function, including phospholipase C and 
synaptotagmins (Chapman, 2002; Rhee and Choi, 1992). Toward this end we mutated the four 
serine residues to alanine in MARCKS-ED, and we found that this prevented the periodic 
dissociation and rebinding of MARCKS-ED to phosphoinositides at the plasma membrane. As 
shown in Figure 2.6, RBL cells were transfected with mRFP-MARCKS-ED SA4 and labeled 
with Ca2+ indicator Fluo-4, which increases in fluorescence with increase in Ca2+ concentration. 
Both Ca2+ mobilization (upper panel) and mRFP-MARCKS-ED SA4 in the cytoplasm (lower 
 34 
 
 
Figure 2.4: Live cell imaging of antigen-stimulated mRFP-MARCKS-ED and 
PKCβI-EGFP oscillations. Representative images showing the distributions of 
PKCβI-EGFP (green) and mRFP-MARCKS-ED (red) before (top panel) and 100 
sec after antigen addition at 25oC (bottom panel) (still frames from Supplemental 
Movies M2.2a and M2.2b). Bars, 10 μm.  
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Figure 2.5: Time courses of cytoplasmic changes of PKCβI-EGFP (blue) 
and mRFP-MARCKS-ED (red) in a region of interest indicated in 
representative RBL cell in Figure 2.4. 
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Figure 2.6: Association of mRFP-MARCKS-ED SA4 with the plasma membrane during 
stimulation by antigen. (A) Images of RBL cells transiently transfected with mutant mRFP-
MARCKS-ED (red) and labeled with the [Ca2+] indicator Fluo-4 (green) at various times of 
stimulation by antigen at 25oC. Images show distributions of labels at time points before 
and after addition of antigen. Bars, 10 μm. (B) Fluorescence intensities from a cytoplasmic 
region of interest in arepresentative cell show that mRFP-MARCKS-ED SA4 (red) remains 
concentrated at the plasma membrane while stimulated [Ca2+] oscillations are observed.  
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panel) were monitored during antigen stimulation. In contrast to results with unmutated 
MARCKS-ED, the SA4 mutant stays associated with the plasma membrane during stimulated 
Ca2+ responses (Figures 2.6A and 2.6B). As illustrated in Figure 2.7 and Supplemental Movie 
M2.3, the onset of Ca2+ responses to antigen in cells expressing mRFP-MARCKS-ED SA4 is 
delayed relative to that for cells not expressing this construct. The average time to onset of the 
Ca2+ response is 162 s (SEM = + 20 s; n = 51) in the presence of this mutated construct, and it is 
67 s (SEM = + 15 s; n = 63) for cells expressing unmutated mRFP-MARCKS-ED. To investigate 
further the effect of MARCKS-ED SA4 expression on Ca2+ mobilization, we compared the Ca2+ 
response to antigen in the absence of extracellular Ca2+, conditions under which the response is 
restricted to IP3-mediated Ca2+ release from ER stores (Lee et al., 2005). As shown for a 
representative cell in Figure 2.8, the transient Ca2+ response in the absence of extracellular Ca2+ 
is delayed for cells expressing mRFP-MARCKS-ED SA4 cells as compared to control cells not 
expressing this mutant. We observed an average delay in the onset of Ca2+ release from stores in 
MARCKS-ED SA4-expressing cells of 200 s (SEM = + 22 s; n = 18) compared to that for 
untransfected control cells. 
 To further characterize the effects of MARCKS-ED SA4 on functional responses, RBL-
2H3 cells were stably transfected with mRFP-MARCKS-ED SA4, and Ca2+ mobilization was 
monitored with indo-1 in a fluorimetry-based assay of suspended cells. As shown in Figure 2.9, 
mRFP-MARCKS-ED SA4-expressing cells exhibit a slower Ca2+ response to antigen when 
compared to the control cells, although the maximal response attained is similar for both. In the 
absence of extracellular Ca2+, control RBL cells show transient Ca2+ release from stores after 
antigen stimulation, returning to the baseline after several hundred seconds (Figure 2.10). This 
response is delayed for RBL cells stably expressing MARCKS-ED SA4. In both cases, addition 
of extracellular Ca2+ results in a rapid increase in intracellular Ca2+ to similar levels, indicating
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Figure 2.7: Ca2+ mobilization in response to Ag at 25oC is delayed in a cell 
expressing mutant mRFP-MARCKS-ED (black) compared with an untransfected cell 
(blue); cells shown in Supplemental Movie M2.3.  
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Figure 2.8: Ca2+ response to antigen in the absence of extracellular 
Ca2+ is substantially delayed in a cell transiently expressing mutant 
mRFP-MARCKS-ED (red) compared with the response in an 
untransfected cell (blue) in the same sample. 
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Figure 2.9: Antigen-stimulated Ca2+ mobilization is delayed in cells stably expressing 
mRFP-MARCKS-ED SA4. Steady state fluorimetry responses to antigen in control 
RBL cells (blue) and cells stably expressing mRFP-MARCKS-ED SA4 (red). 
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Figure 2.10: Ca2+ response to antigen in the absence of extracellular Ca2+ is 
substantially delayed in RBL cells stably expressing mutant mRFP-MARCKS-
ED (red) compared with the response in untransfected cells (blue). Subsequent 
addition of 1.8 mM [Ca2+] results in similar Ca2+ entry for each.  
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 similar activation of store-operated Ca2+ entry. To determine the effect of expression of 
MARCKS-ED SA4 on store-operated Ca2+ entry, independent of PLCγ-mediated release from 
stores, cells were stimulated with thapsigargin. As shown in Figure 2.11, thapsigargin causes a 
rapid increase in cytosolic Ca2+ levels due to leakage of Ca2+ from ER, and this is followed by a 
more sustained phase due to store-operated Ca2+ entry. Cells stably expressing MARCKS-ED 
SA4 showed a similar rapid increase in store-operated Ca2+ influx and a sustained level of store-
operated Ca2+ entry that is somewhat larger than in control cells. These results show that the 
delay in the antigen-stimulated Ca2+ response due to MARCKS-ED SA4 expression is not 
observed for stimulation with thapsigargin, consistent with selective inhibition of antigen-
stimulated PIP2 hydrolysis by MARCKS-ED SA4 and consequent inhibition of IP3-dependent 
Ca2+ release from stores. 
 
 Because of known roles for PKC as well as for Ca2+ mobilization in granule exocytosis, 
we evaluated the effect of MARCKS-ED SA4 expression on degranulation by two different 
methods. In one approach, we loaded granules, which are known to be secretory lysosomes in 
these cells (Dragonetti et al., 2000; Xu et al., 1998), with FITC-dextran by fluid phase 
pinocytosis (Cohen, et al., submitted for publication). Live cell imaging showed transient, single 
granule fusion events as monitored by bursts of FITC fluorescence, which increases when 
exposed to extracellular pH upon antigen stimulation. As represented in Supplemental Movie 
M2.4, we observe that cells transfected with mRFP-MARCKS-ED have delayed onset of 
degranulation events and also a reduced frequency of these fusion events. As illustrated in Figure 
2.12, still movie frames at different time-points show degranulation events starting  1.9 min 
(SEM = + 0.1 min; n = 22) after antigen addition to cells not expressing MARCKS-ED SA4. In 
contrast, we observe that the onset of granule fusion upon antigen stimulation occurs after 5.8 
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Figure 2.11: Ca2+ mobilization in response to thapsigargin in RBL cells stably 
expressing mRFP-MARCKS-ED SA4 (red) is similar compared with the 
response in untransfected RBL cells (blue). 
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Figure 2.12: MARCKS-ED SA4 inhibits antigen-stimulated degranulation monitored 
by real time imaging. Degranulation monitored as FITC-dextran bursts from antigen-
stimulated RBL cells shows delayed and reduced responses in cells expressing mRFP-
MARCKS-ED SA4. Times in images indicate intervals after antigen addition; white 
arrow identifies a cell expressing mRFP-MARCKS-ED SA4. Bars,10 μm. See 
Supplemental Movie M2.4. 
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min (SEM = + 0.2 min; n = 22) in cells that express mRFP-MARCKS-ED SA4. Quantification 
of exocytosis events occurring within 10 min of antigen stimulation reveals reduced exocytosis 
in cells transfected with mRFP-MARCKS-ED SA4 (14.6 + 1.4 average number of fusion events 
per cell; n = 22) compared to untransfected cells in the same sample (46.1 + 4.0 average number 
of fusion events per cell; n = 22). For thapsigargin stimulation, we did not observe any 
significant delay in the onset of fusion events in untransfected cells (6.6 + 0.8 min; n = 7) as 
compared to cells expressing mRFP-MARCKS-ED SA4 in the same sample (7.1 + 0.6 min; n = 
7). Under these conditions, we observed reduced exocytosis events in cells expressing mRFP-
MARCKS-ED SA4 (8.4 + 1.3 average number of fusion events per cell; n = 7) compared to cells 
not expressing this mutant construct in the same sample (15.4 + 2.4 average number of fusion 
events per cell; n = 7). (data not shown). 
 
Because it is difficult to quantify differences in degranulation responses by this real-time 
imaging method, we also utilized a second method in which cells are fixed after stimulation and 
then labeled with anti-CD63 mAb followed by a fluorescent secondary antibody. CD63, also 
known as LAMP2 (Metzelaar et al., 1991), is localized primarily to secretory lysosomes, but a 
small amount is present at the plasma membrane in unstimulated cells. In these experiments, 
unlabeled MARCKS-ED SA4 was co-transfected with the plasma membrane marker PM-EGFP 
that we used to identify transfected cells and also to define the plasma membrane for image 
quantification of localized Alexa555-labeled anti-CD63. As shown in Figure 2.13, labeling of 
CD63 increases at the plasma membrane upon antigen stimulation of RBL cells, and this is 
clearly stronger in non-transfected cells in the same sample. Figure 2.14 quantifies this analysis 
for multiple cells. Some CD63 is evident at the plasma membrane in unstimulated cells, and this 
is similar with and without expression of MARCKS-ED SA4. For antigen-stimulated cells  
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Figure 2.13: Inhibition of degranulation due to expression of MARCKS-ED 
SA4 as monitored by CD63 appearance at the plasma membrane. Representative 
images showing reduced plasma membrane labeling by anti-CD63 due to antigen 
stimulation in cells expressing mutated MARCKS-ED expression. Bars, 10 μm.  
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Figure 2.14: Quantification of anti-CD63 labeling at the plasma membrane for 
unstimulated, antigen-stimulated and thapsigargin-stimulated cells with and 
without expression of MARCKS-ED SA4. Error bars show SEM for 90-100 
cells for each condition from n=6 experiments. P-values from Student’s t-test 
show **P<0.01 for stimulated cells expressing MARCKS-ED SA4 compared 
to stimulated control cells.  
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transfected with PM-EGFP without MARCKS-ED SA4 (control cells), the plasma membrane 
level of CD63 increases by >2.5-fold. By comparison, antigen-stimulated cells expressing 
MARCKS-ED SA4 show a substantially smaller stimulated increase in CD63 at the plasma 
membrane: This stimulated increase was inhibited by ~60% due to expression of MARCKS-ED 
SA4 (n=90-100 for each condition). 
 
We also determined whether MARCKS-ED SA4 inhibits granule exocytosis stimulated 
by thapsigargin, which bypasses PIP2 hydrolysis and IP3-dependent Ca2+ mobilization. In a 
separate set of experiments, we again found no significant effect of MARCKS-ED SA4 on basal 
levels of CD63 at the plasma membrane in unstimulated cells. We observed almost a 3-fold 
increase in CD63 at the plasma membrane due to stimulation by an optimal dose of thapsigargin, 
and this was inhibited by 65% in cells expressing MARCKS-ED SA4 compared to cells 
expressing PM-EGFP alone. Together, these results provide strong evidence that MARCKS-ED 
SA4 exerts a direct inhibitory effect on granule exocytosis. Because MARCKS-ED SA4 has 
been shown to bind tightly to phosphoinositides at the plasma membrane, our results suggest that 
the sequestration of these lipids provides a significant barrier to granule exocytosis. 
 
2.5  Discussion 
 
 Antigen activation of IgE receptors on mast cells results in stimulated granule exocytosis, 
which utilizes Ca2+-triggered membrane fusion and also depends on the activation of PKC. As 
shown by our results, the strong temporal synchronizations of antigen-stimulated oscillations of 
cytoplasmic [Ca2+], PKCβI, and MARCKS-ED (Figures 2.1 – 2.5) are consistent with the 
involvement of [Ca2+ ]-controlled PKCβI activation resulting in phosphorylation of MARCKS as 
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a pathway involved in the regulation of exocytosis. These results are reminiscent of IgE receptor-
stimulated, periodic recruitment of PKCγ-EGFP to the plasma membrane previously 
characterized by Oancea and Meyer (Oancea and Meyer, 1998). The temporal correlation of 
PKCβI-EGFP oscillations that are stimulated by antigen with [Ca2+] oscillations in the cytoplasm 
suggests that [Ca2+] elevation is involved in activation of this PKC isoform. Consistent with this, 
activation of PKCI-EGFP recruitment by antigen is transient in the absence of extracellular 
Ca2+, corresponding to a transient elevation in cytoplasmic [Ca2+] under these conditions 
(Supplementary Figure S2.1). Bypassing IP3-dependent Ca2+ mobilization with thapsigargin 
results in slower, non-oscillatory translocation of PKCβI-EGFP to the plasma membrane (Figure 
2.2B), and this is consistent with slower activation of diacylglycerol production via 
phospholipase D under these conditions (Peng and Beaven, 2005). Stimulated dissociation of 
mRFP-MARCKS-ED from and rebinding to the plasma membrane correspond to the dynamics 
of PKCβI-EGFP oscillatory association with the plasma membrane and are consistent with a role 
for PKC activation in this process. 
 
We find that stimulated dissociation of mRFP-MARCKS-ED is prevented by our SA4 
mutation of the serine residues that are phosphorylated by activated PKC (Figure 2.6), consistent 
with previous studies with MARCKS-ED (Kim et al., 1994).  Heo et al. (2006) showed 
previously that decreased phosphoinositide levels at the plasma membrane cause dissociation of 
MARCKS-ED, and we obtained similar results with our mutant MARCKS-ED SA4 (Smith et 
al., 2010). Thus, the strong temporal synchronizations of oscillations of cytoplasmic [Ca2+], 
PKCβI, and MARCKS-ED under conditions of antigen stimulation are consistent with a role for 
PKCβI in regulating access of PIPs by endogenous MARCKS. The positively charged, polybasic 
peptide sequence MARCKS-ED S4A retains its capacity to bind tightly to highly negatively 
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charged phosphoinositides at the plasma membrane and, importantly, does not dissociate in 
response to activation of PKC. As monitored with both transient and stable expression of this 
construct, we observed a delay in antigen-stimulated Ca2+ mobilization due to this expression, 
consistent with reduced accessibility of PIP2 for hydrolysis by PLCγ (Figures 2.6 – 2.11). 
Despite this delay, the levels of sustained Ca2+ response to antigen are similar in the presence 
and absence of MARCKS-ED S4A. In contrast, stimulation by thapsigargin results in store-
operated Ca2+ entry that is similar in magnitude and kinetics in the presence and absence of 
MARCKS-ED S4A.  
 
The inhibitory effect of MARCKS-ED S4A on the kinetics of antigen-stimulated Ca2+ 
mobilization indicates that the isolated MARCKS-ED segment functions differently in this 
process than when it is part of intact, endogenous MARCKS. This inhibition is due primarily to 
the serine to alanine mutations, because unmutated MARCKS-ED does not inhibit granule 
exocytosis (Figure S2.4). However, inhibitors of PKC activity, such as bisindolylmaleimide I, do 
not inhibit antigen-stimulated Ca2+ mobilization in RBL mast cells (Wolfe et. al., 1996; our data 
not shown), implying that PKC-dependent dissociation of endogenous MARCKS is not 
necessary for PLCγ mediated hydrolysis of PIP2 in these cells. Activation of PKC by phorbol 
esters can negatively regulate antigen-stimulated Ca2+ mobilization, in part by inhibition of PLCγ 
(Ozawa et al., 1993b), but PKC activation by antigen does not normally alter Ca2+ mobilization 
as described above.  These differences may reflect the degree of activation of PKC by phorbol 
ester vs. antigen, but they also suggest some difference in the pools of PIP2 bound by 
endogenous MARCKS and by MARCKS-ED SA4.  
 
We find that MARCKS-ED S4A effectively delays and inhibits granule exocytosis using 
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two different approaches. Real time monitoring of individual granule exocytosis events using 
FITC-dextran (Cohen et al., submitted) permits us to visualize the rate of this process (Figure 
2.12 and Supplemental Movie M2.4). These results clearly reveal a delay in granule exocytosis 
in response to antigen that is predicted by the delay in antigen-stimulated Ca2+ mobilization we 
observe due to transient expression of MARCKS-ED S4A (Figure 2.7). Measurement of the 
stimulated increase in the granule marker CD63 at the plasma membrane permits quantification 
of granule exocytosis following fixation of activated cells. Inhibition of thapsigargin-stimulated 
degranulation to a similar extent as that for antigen demonstrates that MARCKS-ED S4A 
inhibits a step in granule exocytosis that is downstream of Ca2+ mobilization. This step is 
apparently dependent on PKC activation, because expression of the non-mutated MARCKS-ED 
sequence does not inhibit degranulation in similar experiments (Supplemental Figure S2.4). 
 
 What is the mechanism of this inhibition? The previous finding by Heo et al., 2006, 
which showed that MARCKS-ED binds to the plasma membrane primarily through its 
association with phosphoinositides, together with our previous results with MARCKS-ED S4A 
(Smith et al., 2010), make it likely that the functional effects we observe in the present study are 
due to phosphoinositide binding by MARCKS-ED S4A. Certainly, the delay of antigen-
stimulated Ca2+ mobilization, both in the presence and absence of extracellular Ca2+, is readily 
accounted for by the capacity of MARCKS-ED S4A to tie up the pool of PIP2 that is normally 
hydrolyzed by activated PLCγ. Although this electrostatic binding is tight, it is not specific in the 
usual sense of a binding site, and it is possible that PLC or other proteins have limited access to 
PIP2 under these conditions (Gambhir et al., 2004). 
 
The mechanism by which MARCKS-ED S4A interferes with granule exocytosis is also 
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likely to depend on its capacity to bind tightly to phosphoinositides, but the specific interactions 
that are prevented by this association are not yet clear. Synaptotagmins are a family of 
[Ca2+]sensor proteins that participate in multiple exocytotic processes, including mast cell 
degranulation (Sagi-Eisenberg, 2007), and synaptotagmin-2 is the principal isoform that 
mediates granule exocytosis in mast cells (Melicoff et al., 2009). Two C2 domains in 
synaptotagmins bind to Ca2+ and PIP2 to trigger the SNARE-mediated fusion of secretory 
vesicles to the plasma membrane (Li et al., 2006; Schwarz, 2004).  A plausible mechanism for 
the inhibitory effects of mutant MARCKS-ED involves its interference with this PIP2-dependent 
process. A variety of SNARE proteins are expressed in RBL cells, including syntaxin 4, SNAP 
23, VAMP-7 and VAMP-8 (Paumet et al., 2000; Sander et al., 2008), and studies in other cell 
types have provided evidence for a role for PIP2 in regulating syntaxin-1 and VAMP-2-mediated 
membrane fusion (Daily et al., 2010). Thus it is possible that MARCKS-ED S4A affects PIP2 
binding to several different proteins in this process.  
 
It is also possible that other PKC substrates participate in the terminal steps of mast cell 
degranulation. Munc18-1 is a prominent PKC substrate, and disruption of Munc 18-1 association 
with syntaxin-1 inhibits granule fusion events in PC12 cells (Barclay, 2008). In addition to 
phosphorylation by PKC, binding of Ca2+-activated calmodulin to MARCKS causes 
translocation of MARCKS from the plasma membrane and thereby releases sequestered PIP2, as 
reviewed elsewhere (McLaughlin and Murray, 2005). This mechanism of MARCKS-ED 
displacement, which is independent of phosphorylation by PKC, may account for the incomplete 
inhibition of degranulation by MARCKS-ED SA4 that we observe. Overall, our results highlight 
a possible role for PKC in the regulation of PIP2 accessibility, and they establish the utility of 
MARCKS-ED S4A as an effective inhibitor of phosphoinositide-dependent processes. Ligand-
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dependent recruitment of PI 5’-phosphatases can cause acute reduction of plasma membrane 
PIP2 (Stauffer et al., 1998; Varnai and Balla, 1998), but this alternative approach requires co-
expression of multiple constructs that can be difficult to achieve at sufficiently high levels for 
effective interference in some cell types. 
 
 In summary, our results provide mechanistic insights into the regulation of granule 
exocytosis by PKC and phosphoinositides. We have shown that MARCKS-ED S4A stably 
associates with the plasma membrane, delays the onset of antigen-stimulated Ca2+ mobilization 
and degranulation responses, and inhibits both antigen and thapsigargin-stimulated granule 
exocytosis. These effects can be accounted for by tight association of MARCKS-ED SA4 with 
phosphoinositides, although contributions from interactions with other binding partners may also 
contribute to these functional outcomes. PIP2 has been shown to enhance the Ca2+ affinity of 
synaptotagmins, and it may thereby facilitate triggering of secretory granule fusion with the 
plasma membrane. Thus, we propose that PKC is a key to regulating the access of PIP2, such 
that PKC activation during stimulation results in exposure of PIP2 necessary for granule fusion. 
 
2.6  Supplemental Material 
 
Supplementary Figures: 
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Figure S2.1: Stimulation by antigen in the absence of extracellular 
Ca2+ results in transient translocation of PKC to the plasma 
membrane at 37oC, monitored as transient depletion from a region 
of interest in the cytoplasm of a representative cell. 
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Figure S2.2:. Representative images showing less intense anti-
CD63 labeling of thapsigargin-stimulated cells expressing 
MARCKS-ED SA4 as compared to cells not expressing this mutant. 
Bars,10 μm. 
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Figure S2.3: Alexa-555-anti-mIgGγ1 does not label RBL cells in the 
absence of anti-CD63 antibody, demonstrating specificity of 
secondary antibody for the primary antibody in CD63 quantification. 
Bars, 5 μm. 
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Figure S2.4: Quantification of anti-CD63 labeling at the plasma 
membrane for unstimulated, antigen-stimulated and thapsigargin-
stimulated cells with and without expression of MARCKS-ED. Error 
bars show SEM for 25-30 cells for each condition. **P<0.01 for 
antigen-stimulated and thapsigargin-stimulated cells expressing 
MARCKS-ED compared to stimulated cells not expressing MARCKS-
ED. 
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Supplementary movies can be accessed online at: 
http://www.molbiolcell.org/content/early/2011/10/16/mbc.E11-07-0614/suppl/DC1 
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CHAPTER 3 
 
INVESTIGATION OF THE ROLE OF ENDOGENOUS MARCKS PROTEIN IN IgE 
RECEPTOR SIGNALING IN RBL-2H3 MAST CELLS  
 
3.1  Abstract 
 
MARCKS is a ubiquitous substrate for PKC and is involved in multiple signaling processes such 
as cell migration and ruffling in various cell types. Due to its reversible sequesteration of 
phosphoinositides, it is primarily involved in regulating cellular processes that involve PIPs. In 
this study, we present evidence that endogenous MARCKS in RBL cells is involved in 
regulating stimulated Ca2+ mobilization and granule exocytosis. We find that knockdown of 
MARCKS results in inhibition of antigen-stimulated Ca2+ mobilization. Interestingly, we find 
that knockdown of MARCKS, specifically inhibits the store-operated Ca2+ entry (SOCE) 
component of antigen-stimulated Ca2+ mobilization. We also find that MARCKS positively 
regulates antigen-stimulated granule exocytosis, likely, due in part to its regulation of Ca2+ influx 
Based on our results, we hypothesize that endogenous MARCKS regulates antigen-stimulated 
SOCE and granule exocytosis due to its  association with  Ca2+/calmodulin upon cellular 
stimulation. 
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3.2  Introduction 
 
 MARCKS, a prominent PKC substrate, is a major regulator of PIP2 availability in a 
variety of cell types. MARCKS is an anionic protein (pI = 4.5 - 4.7) due to the presence of a 
large number of negatively charged amino acids. Its molecular weight is 30 kDa, however, it 
migrates at 80 kDa in an SDS-PAGE gel due to a high net negative charge (Erusalimsky et al., 
1991; Graff et al., 1989a; Harlan et al., 1991; Stumpo et al., 1989).  
 
 MARCKS has a very concentrated basic stretch of amino acids (from 151-175 in the full 
length MARCKS sequence) called the effector domain (ED) with a net positive charge of 13. 
MARCKS-ED is responsible for most of the known interactions of MARCKS with PIPs, 
calmodulin and F-actin (Blackshear, 1993; Glaser et al., 1996; Hartwig et al., 1992). Due to the 
presence of over ten lysine residues in MARCKS-ED, the effector domain associates with the 
negatively charged PIPs at the plasma membrane due to electrostatic interactions. Apart from the 
basic amino acids, this effector domain also has four serine residues, three of which get 
phosphorylated by PKC causing the disruption of MARCKS interaction with PIPs and the 
dissociation of MARCKS from the plasma membrane.  
 
The translocation of MARCKS into the cytosol can also be caused by Ca2+/calmodulin 
binding to MARCKS. Calmodulin is a Ca2+ binding protein, present in the cytosol, and it is 
known to bind lysine rich motifs.   A rise in intracellular Ca2+ leads to calmodulin activation 
upon Ca2+ binding. Ca2+/calmodulin binds to the effector domain of MARCKS leading to the 
translocation of Ca2+/calmodulin bound MARCKS into the cytosol.  
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We previously proposed in Chapter 2 that PKC activation regulates accessibility of PIPs 
under stimulated conditions due to the capacity of PKC to reversibly disrupt the electrostatic 
interactions between PIPs and MARCKS-ED (McLaughlin and Murray, 2005). In the current 
study, we have explored the molecular mechanism by which full-length endogenous MARCKS 
participates in regulating stimulated Ca2+ mobilization and granule exocytosis.  
 
 The store-operated Ca2+ entry (SOCE) component of Ca2+ mobilization requires two key 
proteins: STIM1, an ER transmembrane Ca2+ sensor, and Orai1, which is a plasma membrane 
Ca2+ channel subunit. In the current study, we present evidence for a possible regulatory role of 
MARCKS in antigen-stimulated SOCE and also in granule exocytosis. 
 
 3.3  Experimental 
 
Cell culture 
RBL cells culture is previously described (Chapter 2). 
 
Immunoprecipitation and Western Blotting 
 MARCKS was immunoprecipitated using rabbit anti-rat MARCKS polyclonal antibody 
(Abcam). After harvesting, cells were washed and resuspended in BSS at a concentration of 
9x106 / ml. 900 µl of 2X solubilization buffer (20 mM Tris, 100 mM NaCl, 2 mM Na3VO4, 60 
mM Na4P2O7, 0.04 U/ml aprotinin, 0.02% NaN3, 1.0% TritonX-100, 2 mM AEBSF (4-(2-
Aminoethyl) benzenesulfonyl fluoride), and a protease inhibitor cocktail) was added to 900 µl 
cells and incubated on ice for 10 min. Cells were centrifuged at 11000 rpm at 4ºC for 10 min, 
and the supernatant was incubated with 25 µl of Protein A beads (Pierce) and 5 µg anti-
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MARCKS antibody at 4ºC for 2 hrs on a rotator. A control sample was incubated with 5 µg anti-
Rab11 antibody. After incubation, beads were pelleted and washed thrice with 1X solubilization 
buffer (500 µl each) at 2000 rpm for 1 min to remove unbound antibody. The beads were 
resuspended in 80 µl of 1X SDS sample buffer (50% glycerol, 5% SDS, 0.1% bromophenol blue 
in 0.25 M Tris) and boiled for 5 min. For reduced samples, 1% β-mercaptoethanol v/v (BME) 
was also added before boiling.  
 
 Immunoprecipitated product samples were electrophoresed on a 10% polyacrylamide gel 
and run at 25 mA for 1 hr. The electrophoresed proteins were transferred to a polyvinylidene 
fluoride (PVDF) membrane using a semidry transfer apparatus at 90 mA for 1 hr. The membrane 
was blocked with 15% BSA (w/v) in Tris-buffered saline with Tween (TBST, 50 mM Tris, pH 
7.6, 1 M HCl, 150 mM NaCl and 0.1% Tween 20). To detect MARCKS, the primary antibody 
was used at 1:10,000 dilution. Biotin SP-goat anti-rabbit IgG (Jackson ImmunoResearch 
Laboratories) was used at 1:3000 as the secondary antibody, followed by Neutraavidin-
conjugated horseradish peroxidase (Pierce) at 1:1000 as the tertiary antibody. Blots were 
developed using Super Signal West Pico chemiluminescent substrates. Blotting of   
immunodepleted products was carried out similarly using an aliquot of supernatant of beads after 
pull-down with antibody. 
 
siRNA design  
 Two short-interfering RNA (siRNA) nucleotides for gene-silencing of MARCKS were 
selected from the predicted mRNA sequence of MARCKS (Rattus Norvegicus) published in 
PubMed. siRNA A was selected from a previously published result (Calabrese et. al., Neuron, 
2005). siRNA B was selected in close proximity to the mRNA sequence of effector domain of 
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MARCKS. The siRNAs were purchased from Thermo Scientific Dharmacon. 
siRNA A: CUGUACCAGUCAGUAAUUAUU  
siRNA B: GGAGAAUGGCCACGUAAAAUU 
 
siRNA knockdown  
 siRNA-mediated RNA interference was induced in RBL-2H3 cells by electroporation 
with 1 µM siRNA A, siRNA B, or control siRNA under stringently sterile conditions. 
Electroporated cells were plated in 25 cm2 cell culture flasks and 24 hrs later a second 
knockdown was performed as above in the respective samples and plated in 25 cm2 cell culture 
flasks. 48 hrs post-second electroporation, cells were harvested and suspended in BSS and used 
for functional assays. 
 
Ca2+ measurement 
 Intracellular Ca2+ measurement of suspended cells loaded with indo-1 was carried out in 
a stirred cuvette using steady-state fluorimetry as described in Chapter 2. For quantification of 
Ca2+ response, background fluorescence obtained with EDTA was subtracted from the actual 
fluorescence value and TritonX-100 treated fluorescence value and their ratio was determined. 
The normalized Ca2+ response was integrated over 300-500 s after stimulation. To determine the 
percentage inhibition of Ca2+ response in MARCKS knockdown cells, the integrated Ca2+ 
response from knockdown cells was subtracted from the integrated Ca2+ response from control 
cells (treated with arbitrary siRNA sequence). The ratio of this difference in the integrated Ca2+ 
response and integrated Ca2+ response from control cells was multiplied by 100 to get the 
percentage inhibition. 
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Granule exocytosis monitored in suspended cells with FITC-dextran 
 Cells were loaded with 2 mg/ml FITC-dextran (10,000 MW from Sigma-Aldrich) 24 hrs 
prior to monitoring granule exocytosis. FITC-dextran loaded cells were washed 3 times with 
BSS and resuspended at a concentration of 3X106/ml and aliquoted into a cuvette. Time-based 
acquisition of FITC-dextran release was monitored in an SLM 8100C fluorimeter, and cells were 
stimulated with 0.2 µg/ml DNP-BSA or 20 ng/ml with 1µg/ml cytochalasin D or 0.5 µM 
thapsigargin with 50 nM PMA.  For quantification of granule exocytosis, baseline fluorescence 
before stimulation was subtracted from the actual fluorescence value and TritonX-100 treated 
fluorescence value and their ratio was determined. This normalized granule exocytosis response 
was integrated over 500-1000 s after stimulation. To determine the percentage inhibition of 
granule exocytosis in MARCKS knockdown cells, the integrated granule exocytosis response 
from knockdown cells was subtracted from the integrated granule exocytosis response from 
control cells (treated with arbitrary siRNA sequence). The ratio of this difference in the 
integrated  response and integrated response from control cells was multiplied by 100 to get the 
percentage inhibition. 
 
3.4  Results 
 
 As previously shown in Chapter 2, the strong temporal synchronization of antigen-
stimulated PKCβI and MARCKS-ED oscillations implicates a role for PKC-mediated MARCKS 
phosphorylation in regulating the interactions between this protein and the plasma membrane. To 
investigate the role of endogenous MARCKS in mast cell signaling, we knocked down 
endogenous MARCKS and assessed the effect on signaling processes. We first tried to ascertain 
the expression level of endogenous MARCKS in RBL-2H3 cells by performing 
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immunoprecipitation with an anti-MARCKS antibody. We detected a band at 80 kDa by western 
blotting of the immunoprecipitated product (Figure 3.1). As shown in the literature, MARCKS 
electrophoreses in the molecular weight range of 80-90 kDa in an SDS-PAGE gel due to its 
highly anionic net charge. We tested the specificity of this antibody for MARCKS by 
electrophoresing the immunodepleted samples after MARCKS or Rab11 (control) pull-down and 
blotting with anti-MARCKS antibody. As shown in Figure 3.2, it appears that the 80 kDa band 
detected by this antibody is non-specific. We also tried another antibody for MARCKS from 
GenScript which failed to show any band at 80 kDa (data not shown). 
 
 Given the strong electrostatic interactions between MARCKS and phosphoinositides 
(McLaughlin and Murray, 2005), we were interested in the effects of knockdown of MARCKS 
on PIP-dependent processes in mast cells. To investigate the possible role of MARCKS in 
stimulated-Ca2+ mobilization in RBL cells, we measured Ca2+ levels in suspended siRNA-
mediated MARCKS knockdown cells using steady-state fluorimetry. As shown in the 
representative experiment in Figure 3.3, cells with siRNA A or siRNA B, exhibited 25 + 5% (n = 
4) inhibition of antigen-stimulated Ca2+ mobilization, suggesting that MARCKS plays a positive 
regulatory role in this process.  
 
 To determine if MARCKS regulates the availability of the pool of PIP2 that is hydrolyzed 
by PLCγ to produce IP3, we examined the Ca2+ response to antigen in the absence of 
extracellular Ca2+ in siRNA treated cells. As shown in the representative experiment in Figure 
3.4, we found that there is no consistent difference in IP3-dependent Ca2+ release from ER stores 
due to knockdown of MARCKS. However, interestingly, we found that addition of extracellular 
Ca2+ following stimulation results in inhibition of SOCE by 31 + 7% (n = 5) in cells which were  
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Figure 3.1: Western blot of immunoprecipitated product with 
MARCKS antibody shows up at 80 kDa; immunoprecipitation with 
Rab11 as a control does not show any band in that molecular weight 
range. Both MARCKS and Rab 11 immunoprecipitated products 
were blotted with MARCKS antibody. 
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Figure 3.2: Western blot of whole cell lysate of RBL cells (before IP 
lane) and supernatants after immunoprecipitation with MARCKS and 
Rab 11 antibody show 80 kDa band. MARCKS antibody was used for 
blotting. 
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Figure 3.3: Steady-state fluorimetry of Ca2+ response to antigen in 
control RBL cells (blue) and cells with MARCKS knockdown (red for 
siRNA A treated cells and green for siRNA B treated cells).  
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Figure 3.4: Steady-state fluorimetry shows antigen-stimulated Ca2+ response to 
antigen in the absence of extracellular Ca2+ followed by antigen-stimulated SOCE due 
to addition of extracellular Ca2+. Control cells (blue), siRNA A treated cells (red) and 
siRNA B treated cells (green). Buffer had 1.8 mM Ca2+ and it was chelated with 2 mM 
EGTA before antigen stimulation to monitor the response in the absence of 
extracellular Ca2+. 
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treated with MARCKS siRNA, with similar inhibition levels for both siRNA A and siRNA B. 
This suggests that MARCKS is strongly modulating antigen-stimulated SOCE. We also 
determined the effect of MARCKS RNAi on SOCE stimulated by thapsigargin as shown in 
Figure 3.5, and found small amount of inhibition with limited data (10%; n = 2).  
 
  Results in Chapter 2 supported the role of PIP2 in mediating granule exocytosis in mast 
cells, and our data suggested that this is regulated by PKC-dependent phosphorylation of 
MARCKS-ED. We investigated whether knockdown of endogenous MARCKS has an effect on 
granule exocytosis stimulated by antigen or thapsigargin. We performed steady-state fluorimetry 
of FITC-dextran-loaded cells in a stirred cuvette to monitor granule exocytosis. As represented in 
Figure 3.6, we observed 42 + 6% (n = 4) inhibition of antigen-stimulated degranulation in 
MARCKS knockdown cells as determined by the integrated FITC fluorescence response over 15 
minutes after stimulation. This observation suggests that endogenous MARCKS positively 
regulates granule exocytosis through some other pathway also that may or may not involve PIPs.  
Since granule exocytosis in suspended cells is a kinetically slower process, we enhanced it by 
pre-treating the cells with cytochalasin D and then stimulated with antigen. As shown in Figure 
3.7, we observed a higher rate of granule exocytosis under these conditions for both control and 
siRNA-knockdown cells, and the inhibitory effect of MARCKS-knockdown on degranulation 
was somewhat lower (30 + 3%, n = 2) as compared to the effect observed without cytochalasin 
D. 
 
 We also investigated the effect of endogenous MARCKS on thapsigargin-stimulated 
degranulation in the presence of PMA to achieve a detectable response. We found no difference 
in the degranulation response of control cells and siRNA-treated cells as shown in Figure 3.8. It  
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Figure 3.5: Ca2+ mobilization in response to thapsigargin in control RBL cells 
(blue), siRNA A treated cells (red) and siRNA B treated cells (green).  
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Figure 3.6: Steady-state fluorimetry to monitor degranulation as FITC-
dextran release from antigen-stimulated control RBL cells (blue), 
siRNA A treated cells (red) and siRNA B treated cells (green). 
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Figure 3.7: Steady-state fluorimetry to monitor antigen-stimulated degranulation 
after pre-treatment with cytochalasin D. FITC-dextran release from antigen-
stimulated control RBL cells (blue) and siRNA A treated cells (red). 
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Figure 3.8: Steady-state fluorimetry to monitor degranulation as FITC-
dextran release from thapsigargin and PMA-stimulated control RBL cells 
(blue) and siRNA A treated cells (red). 
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is possible that addition of PMA might have compensated for any inhibitory effect that might 
occur for thapsigargin stimulation in the absence of PMA, but this response was insufficient to 
permit evaluation.  
 
 Thus, our results provide evidence for modulation of antigen-stimulated SOCE by 
endogenous MARCKS in RBL cells. We also observe positive regulation of antigen-stimulated 
granule exocytosis by MARCKS, likely, due in part to its role in SOCE. 
 
3.5  Discussion 
 
 Our data provides substantial evidence that endogenous MARCKS participates in 
regulating antigen-stimulated SOCE and granule exocytosis in RBL cells.  To account for our 
findings, we hypothesize that MARCKS regulation of SOCE is due to its interaction with other 
binding proteins, most likely, calmodulin. It has been speculated that PKC-dependent 
phosphorylation of MARCKS prevents binding of MARCKS to Ca2+/calmodulin (Graff et al., 
1989b), indicating that PKC phosphorylating MARCKS and Ca2+/calmodulin binding to 
MARCKS are competing processes. There is also evidence in the literature showing that 
MARCKS dissociates from MARCKS-Ca2+/calmodulin complex upon PKC phosphorylation, 
and this causes activation of other calmodulin-dependent pathways (McIlroy et al., 1991). 
McIlroy and colleagues also show in this study that binding of MARCKS-ED to calmodulin 
inhibits the interaction of calmodulin with its other binding partners, most notably myosin light 
chain kinase, indicating that MARCKS can control the availability of calmodulin for its 
interaction with its partner proteins. Recently, it was demonstrated by Mullins and colleagues 
(Mullins et al., 2009) that binding of calmodulin with STIM1 causes inhibition of SOCE. Based 
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on the above findings and our data with knockdown of MARCKS, we hypothesize that 
association of MARCKS with Ca2+/calmodulin is the key to regulating calmodulin-STIM1 
interaction, thereby regulating STIM1-mediated inactivation of SOCE. As depicted in Figure 3.9, 
a rise in intracellular Ca2+ causes Ca2+/calmodulin binding to MARCKS, however, calmodulin 
can also bind to STIM1 if calmodulin is not bound to MARCKS. In MARCKS knockdown cells, 
we observe reduced antigen-stimulated SOCE (Figure 3.4), most likely because calmodulin 
cannot be sequestered by MARCKS due to its low expression. Therefore, calmodulin is available 
to bind to STIM1, causing STIM1-mediated inactivation of SOCE. We thus speculate that the 
role of MARCKS in mast cell signaling is to inhibit the STIM1-mediated inactivation of SOCE 
and hence it is positively regulating SOCE.       
 
 We also provide evidence for the participation of endogenous MARCKS in positively 
regulating antigen-stimulated granule exocytosis in mast cells. It is well established that SOCE is 
important for stimulated degranulation in mast cells, so inhibition of SOCE in MARCKS 
knockdown cells would cause significant inhibition of stimulated granule exocytosis. 
Additionally, previous studies have suggested that PKC-dependent phosphorylation of 
MARCKS causes F-actin disassembly which facilitates granule exocytosis in platelets and 
chromaffin cells (Trifaro et al., 2008).  It is possible that in MARCKS RNAi cells, there is 
inhibition of F-actin disassembly (which in control cells is regulated by PKC-mediated 
MARCKS phosphorylation), and this enhances inhibition of stimulated granule exocytosis in 
these cells as compared to control cells. 
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Figure 3.9: Schematic diagram showing Ca2+/calmodulin binding to MARCKS 
causing a translocation of Ca2+/calmodulin bound MARCKS into the cytosol. The 
diagram also shows another binding partner for calmodulin – STIM1. 
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CHAPTER 4 
 
 
SUMMARY AND FUTURE DIRECTIONS 
 
 
 This dissertation illuminates the role of PKCβI, MARCKS-ED and PIP2 in regulation of 
granule exocytosis in RBL mast cells. We utilize mutated MARCKS-ED (MARCKS-ED SA4) 
as a tool to investigate PKC-dependent exposure of PIP2 in perturbing cellular signaling. We 
further probe the role of endogenous MARCKS by knocking down its expression to get a more 
detailed view of MARCKS in mast cell signaling. Drawing from our combined results from 
expression of mutated MARCKS-ED and knockdown of endogenous MARCKS, we propose that 
MARCKS exerts both positive and negative regulation on stimulated granule exocytosis. This is 
finely tuned by two parallel pathways dependent on MARCKS translocation into the cytosol. 
 
 It is well established in the literature that PKCβI plays an important role in granule 
exocytosis of mast cells, but the mechanism remains poorly understood. In chapter 2, we 
investigated the spatial and temporal changes of PKCβI-EGFP using real-time fluorescence 
imaging, and we conclude that PKCβI oscillations follow the time course of Ca2+ oscillations as 
shown in figure 2.3. To monitor the activity of PKCβI at the plasma membrane, we co-expressed 
PKCβI substrate mRFP-MARCKS-ED and demonstrated that its displacement from the plasma 
membrane is synchronized with the oscillatory recruitment of PKCβI to the plasma membrane as 
illustrated in figure 2.5. Hence, we demonstrated that PKC and MARCKS-ED show oscillatory 
association with the plasma membrane due to changes in intracellular Ca2+ levels. 
 
MARCKS is well known for its association with phosphoinositides at the plasma 
membrane. We evaluated the capacity of PKC-mediated phosphorylation of MARCKS-ED in 
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regulating PIP2 availability at the plasma membrane and its possible role in stimulated granule 
exocytosis. For this purpose, we created MARCKS-ED which lacks the capacity to be 
phosphorylated by PKC because we mutated serine residues to alanines. We showed in figures 
2.6 and 2.7 that antigen-stimulated Ca2+ mobilization in RBL cells expressing MARCKS-ED 
SA4 is delayed possibly due to inhibition of PIP2 hydrolysis by PLCγ, consistent with limited 
availability of PIP2 in this case. Under similar conditions, we observed that SOCE stimulated by 
antigen and thapsigargin is not inhibited as observed in figures 2.10 and 2.11. These results 
indicate that only the release from stores component of Ca2+ mobilization that is affected by 
MARCKS-ED SA4 expression.  
 
There is growing evidence in the literature to suggest that PIP2 plays an important role in 
vesicle fusion. High concentration of PIP2 has been observed at the sites of vesicle docking in 
PC12 membrane sheets (James et al., 2008). It has also been speculated that the presence of PIP2 
in membrane enhances the affinity of Ca2+ towards synaptotagmin and facilitates the insertion of 
Ca2+/synaptotagmin complex into the membrane, thereby, triggering vesicle fusion (Bai et al., 
2004). We investigated the effect of sequestration of PIP2 on granule exocytosis using 
MARCKS-ED SA4 as a probe to perturb PIP2 availability at the plasma membrane. With both 
antigen and thapsigargin stimulation we observed reduced granule exocytosis, thereby 
supporting the model of PIP2 availability being an important factor in the downstream events 
leading to granule exocytosis. Delayed Ca2+ release from stores upon antigen stimulation may 
contribute to reduced granule exocytosis. However, using thapsigargin as a stimulus and 
bypassing IP3-mediated Ca2+ mobilization, we still observe similar inhibitory level of granule 
exocytosis as observed with antigen stimulation. As described previously for thapsigargin 
stimulation, we did not observe inhibition of Ca2+ mobilization upon expression of MARCK-ED 
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SA4. Thus, our studies in chapter 2 lead us to conclude that expression of MARCK-ED SA4 
results in a direct inhibition of granule exocytosis, most likely due reduced availability of PIP2 to 
interact with its binding partners like synaptotagmin, an interaction which is critical for granule 
exocytosis. We also showed that over-expression of the wild type sequence of MARCKS-ED 
does not cause inhibition of granule exocytosis, in contrast to the non-phosphorylatable 
MARCKS-ED SA4 mutant expression, thus indicating that PKC activity at the plasma 
membrane controls the availability of PIP2 to participate in granule exocytosis.   
 
Furthermore, to understand the role of endogenous MARCKS in mast cell signaling, we 
performed RNA interference in RBL cells to knock down this protein. We observed that reduced 
levels of endogenous MARCKS results in perturbation of stimulated mast cell signaling. 
Interestingly, we observed that knockdown of MARCKS causes a significant reduction in SOCE 
stimulated by antigen, but it does not have an effect on Ca2+ release from stores. Not 
surprisingly, we also observed reduced antigen-stimulated granule exocytosis due to MARCKS 
siRNA, indicating that under physiological conditions, MARCKS positively regulates antigen-
stimulated SOCE and granule exocytosis. This was contradictory to our hypothesis in chapter 2, 
in which we proposed that MARCKS negatively regulates granule exocytosis because it 
reversibly binds to PIP2 at the plasma membrane, thereby, limiting the availability of PIP2 to 
participate in granule exocytosis events. We were aware of our preliminary results in chapter 3 
and hence we were very careful in stating our hypothesis in chapter 2. We used MARCKS-ED 
SA4 as a tool to perturb PIP-dependent signaling in stimulated RBL cells in chapter 2, but these 
results cannot be used to conclusively state the role of endogenous full length MARCKS in 
signaling. A survey of the literature reveals that in addition to being a target for phosphorylation 
by PKC, MARCKS also interacts with Ca2+ bound calmodulin (Arbuzova et al., 2002). 
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Ca2+/calmodulin binds to lysine rich protein motifs. The effector domain of MARCKS which 
contains the serine residues that get phosohorylated by PKC, also has the lysine rich amino acid 
sequence which is a target for Ca2+/calmodulin. A rise in intracellular Ca2+ causes calmodulin 
activation leading to Ca2+/calmodulin binding to MARCKS, and this results in translocation of 
Ca2+/calmodulin-bound MARCKS to the cytosol. An interesting finding in the literature points 
towards the role of Ca2+/calmodulin in negatively regulating SOCE. Mullins et al. provide 
evidence for a mechanism suggesting that Ca2+/calmodulin binds to STIM1 leading to inhibition 
of SOCE (Mullins et al., 2009).  
 
Our data in chapter 3 show reduced antigen-stimulated SOCE and granule exocytosis by 
knocking down MARCKS, and from the literature we surmise that MARCKS interacts with 
Ca2+/calmodulin and Ca2+/calmodulin binds to STIM1 leading to decreased SOCE. Based on this 
information, a plausible explanation for our results is that low expression level of MARCKS 
causes a higher free concentration of Ca2+/calmodulin as it is not fully sequestered by 
endogenous MARCKS upon stimulation. A higher free concentration of Ca2+/calmodulin would 
imply that more Ca2+/calmodulin is available to bind to STIM1, thereby, leading to higher 
STIM1-mediated inactivation of SOCE as compared to control cells which were treated with an 
arbitrary siRNA sequence. We thus hypothesize in chapter 3 that association of MARCKS with 
Ca2+/calmodulin under stimulated conditions inhibits the interaction of Ca2+/calmodulin with 
STIM1, hence positively regulating SOCE and granule exocytosis. 
 
In summary, we have developed a very useful tool - MARCKS-ED SA4, to sequester 
PIPs at the plasma membrane and we demonstrated with multiple investigations, its capacity to 
perturb PIP2-dependent signaling. Due to the lack of PIP5K inhibitors which synthesize PIP2, 
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MARCKS-ED SA4 can be a very attractive probe to investigate the role of PIP2 in various 
signaling cascades in which PIP2 plays a key role, but the mechanism of its participation is not 
well understood. Also, our results combined from chapter 2 and 3, reveal that endogenous 
MARCKS has both positive and negative regulatory roles in signaling. As shown by our 
experimental data with MARCKS-ED SA4, we hypothesize that endogenous MARCKS 
reversibly sequesters PIPs until they are dissociated by PKC phosphorylation, thereby, exerting a 
negative regulatory role on granule exocytosis prior to cell activation. However, in parallel, 
endogenous MARCKS also interacts with Ca2+-bound calmodulin after a rise in intracellular 
Ca2+ upon cell stimulation. Binding of MARCKS to Ca2+/calmodulin results in sequestration of 
calmodulin, thereby limiting the interaction of calmodulin with STIM1, thus, enhancing SOCE, 
and this leads to increased granule exocytosis. Hence, MARCKS regulates granule exocytosis in 
a finely tuned manner due to its participation in two independent pathways as depicted in figure 
4.1, both of which ultimately lead to granule exocytosis. As shown in chapter 2, one pathway 
illuminates the negative regulation of granule exocytosis due to PKC-mediated MARCKS 
phosphorylation leading to availability of PIP2 to participate in stimulated granule exocytosis. As 
illustrated in chapter 3, the other pathway reveals the positive regulation of SOCE by MARCKS, 
which is critical for stimulated granule exocytosis, thereby enhancing it.  
 
We can test our hypothesis of MARCKS involvement in two pathways leading to 
degranulation with a calmodulin inhibitor that inhibits the interaction of Ca2+/calmodulin with 
STIM1. RBL cells expressing normal levels of endogenous MARCKS, treated with a calmodulin 
inhibitor, are expected to show higher antigen-stimulated SOCE as compared to cells not treated 
with the inhibitor under similar conditions. If our hypothesis is correct then there would be no 
inhibition of antigen-stimulated SOCE in MARCKS knockdown cells treated with calmodulin  
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Figure 4.1: MARCKS participation in two independent pathways. Left side shows 
Ca2+/calmodulin binding to MARCKS leading to translocation of Ca2+/calmodulin 
bound MARCKS into the cytosol. Right side represents phosphorylation of MARCKS 
by PKC resulting in translocation of phosphorylated MARCKS into the cytosol. 
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inhibitor as compared to control cells not treated with MARCKS siRNA and calmodulin 
inhibitor. Conversely, if cells expressing MARCKS-ED SA4, are treated with calmodulin 
inhibitor, then they would be expected to show enhanced antigen-stimulated SOCE as compared 
to MARCKS-ED SA4 expressing cells not treated with calmodulin inhibitor. However, antigen-
stimulated granule exocytosis in cells expressing MARCKS-ED SA4 and in the presence of 
calmodulin inhibitor will be inhibited but to a lesser extent compared to the percentage inhibition 
observed due to expression of MARCKS-ED SA4 alone. We expect reduced inhibition of 
antigen-stimulated granule exocytosis in cells which express MARCKS-ED SA4 and have been 
treated with calmodulin inhibitor as compared to cells expressing MARCKS-ED SA4 but not 
treated with calmodulin inhibitor due to the predicted higher SOCE in the former case but not in 
the latter. We expect that higher SOCE will counteract the inhibitory effect of MARCKS-ED 
SA4 in stimulated granule exocytosis in cells treated with calmodulin inhibitor. This would help 
support our hypothesis. 
 
We expressed full-length wild type MARCKS tagged with mRFP in RBL cells and upon 
antigen stimulation observed periodic dissociation and association with the plasma membrane as 
seen with mRFP-MARCKS-ED (data not shown). In the future, we would also like to confirm 
our results shown with MARCKS-ED SA4 with full-length MARCKS SA4. We would expect 
that full-length MARCKS with the SA4 mutation will show inhibitory effect on stimulated 
granule exocytosis similar to those we observed with MARCKS-ED SA4. Full-length MARCKS 
SA4 retains myristoylation at its N-terminus. It would be interesting to determine if this mutant 
exhibits a preference for ordered lipid pool of PIP2 at the plasma membrane and compare it with 
MARCKS-ED association with PIP2 at the plasma membrane. There is growing evidence in the 
literature for different pools of PIP2 regulating different set of pathways. It would be of interest 
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to create a mutant MARCKS probe that can differentially associate with PIP2 in ordered lipid 
pool vs. disordered lipid pool. This would help us gain mechanistic insights to see if there is a 
specific pool of PIP2 that regulates stimulated granule exocytosis. 
 
Another approach to show that expression of MARCKS-ED SA4 delays antigen-
stimulated Ca2+ from stores due to delayed hydrolysis of PIP2, is to determine the rate of IP3 
production under these conditions. We would expect delayed IP3 production in MARCKS-ED 
SA4 expressing cells stimulated by antigen as compared to cells expressing wild type MARCKS-
ED. It would be of interest to correlate the time of delay in IP3 production to the time of delay in 
Ca2+ release.  
 
Having shown that MARCKS-ED SA4 inhibits stimulated granule exocytosis, we would 
like to take our experiments one step further down the signaling cascade to see if expression of 
this mutant has an effect on cytokine production. The rapid release of pre-formed chemical 
mediators from mast cells is followed by de novo synthesis and secretion of various cytokines 
over the course of hours (Qiao et al., 2006). An effect on cytokine production or secretion due to 
expression of MARCKS-ED SA4 can throw light on the involvement of PIP2 in this process if 
there is any.   
 
A major limitation to interpreting our results has been our inability to correlate the level 
of MARCKS knockdown to its effect on inhibiting SOCE and granule exocytosis. We have thus 
far been unable to determine the percentage of reduced protein expression in MARCKS 
knockdown cells due to the lack of a rat specific MARCKS antibody. We suggest the use of 
reverse transcription polymerase chain reaction (RT-PCR) to determine the level of endogenous 
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MARCKS, which would be based on the mRNA sequence determined from the cDNA library 
generated for RBL cells. If we can show that as the percentage of MARCKS expression 
decreases we observe similar percentage reduction in antigen-stimulated SOCE and granule 
exocytosis, then it would support our results suggesting that MARCKS has a direct positive 
regulatory effect on stimulated signaling. 
 
It would be of interest to see whether a phosphomimetic mutant of MARCKS, in which 
serine residues are mutated to glutamate, to mimic the phosphorylated state of MARCKS would 
have an effect on mast cell signaling. We would expect that expression of phosphomimetic 
MARCKS (cytosol localized) will not have any effect on antigen-stimulated release of Ca2+ from 
stores, SOCE or stimulated granule exocytosis as it would not interact either with PIP2 or with 
Ca2+/calmodulin with or without stimulation. 
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 APPENDIX 1 
 
 
DNP-FUNCTIONALIZED POLYMERS TO ENGAGE RECEPTORS AND CONTROL 
CELLULAR RESPONSES IN MAST CELLS 
 
 
A.1 Abstract 
 
 
Functionalized polymers α,ω-bi[2,4-dinitrophenyl][poly(ethylene oxide)- poly(2-
methoxystyrene)- poly(ethylene oxide)] (DNP-PEO-P2MS-P2MS(-SO3Na)-PEO-DNP) and 
biodegradable polylactide polymers α,ω-bi[2,4-dinitrophenyl(DNP)] [Poly(lactide)-β-
Poly(ethylene glycol)-β-Poly(lactide)] with variable molecular weights and structures were 
synthesized. Incorporation of PEO and sulfonation enhance their solubility. We demonstrate here 
that they bind specifically to anti-DNP IgE in solution and to IgE-receptor complexes on RBL-
2H3 cells. Although these DNP-functionalized ligands do not stimulate the granule exocytosis 
response, they have the potential to inhibit the robust response stimulated by other multivalent 
DNP ligands. Binding and degranulation studies carried out with these polymers are useful for 
learning how specific ligands that crosslink IgE-receptors control the cellular response. Further, 
this type of characterization provides useful information for the development of better inhibitors 
of potent allergens. In separate studies, we show the potential of these functionalized polymers to 
be utilized in biosensors due to their specificity for IgE binding, after the polymers are 
electrospun with carbon nanotubes on silicon substrates.  
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A.2 Introduction 
 
 
 Allergic reactions mediated by the IgE antibody require clustering of IgE-FcεRI on mast 
cell surface by bivalent or multivalent ligands, and this is a key step for initiating signal 
transduction resulting in granule exocytosis. IgE antibody has two Fab segments, each of which 
binds an antigenic group. Crosslinking of anti-DNP IgE-FcεRI complexes can be controlled by 
the orientation and flexibility of DNP ligands with varying lengths, composition, and DNP 
valency. Previous studies demonstrated that monovalent ligands do not stimulate mast cells due 
to lack of crosslinking, whereas multivalent ligands can successfully cause cell activation. 
Bivalent ligands can act as either triggers or inhibitors of granule exocytosis depending on 
whether they bind intermolecularly (activation) or intramolecularly (inhibition) (Baird et al., 
2003; Kane et al., 1988). 
 
 Multivalent DNP16-BSA (DNP conjugated to bovine serum albumin) is commonly used 
to trigger activation of RBL-2H3 cells, but it cannot be used to decipher structural requirements 
due to its heterogeneity. Also, DNP tends to be sequestered within BSA and thereby not readily 
accessible to IgE (Xu et al., 1998). Previously our lab synthesized structurally well-defined rigid 
DNA ligands functionalized with DNP to gain mechanistic insights into the IgE-FcεRI cross-
linking requirement of mast cell signaling (Sil et al., 2007). 
 
 In the present study, we investigated a series of DNP-functionalized poly(2-
methoxystyrene) polymers (P2MS) synthesized by researchers at Clark Atlanta University 
(CAU) (Figure A.1). We tested these polymers for their capacity to bind to anti-DNP IgE and 
their potential to stimulate or inhibit degranulation.  Aqueous solubility of these polymers was  
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Figure A.1:  Polystyrene polymer structure corresponding to DNP-(PEO)x-
(P2MS)m-P2MS(-SO3Na)n-(PEO)-DNP above. Biodegradable polylactide structure 
below: α,ω-bi[2,4-dinitrophenyl(DNP)] [Poly(lactide)-β-Poly(ethylene glycol)-β- 
Poly(lactide)]. 
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enhanced by incorporation of PEO and sulfonation.  
 
We also characterized a polylactide polymer (structure shown in figure A.1) synthesized 
at CAU. Polylactides can be degraded by hydrolysis of the ester linkage, resulting in non-toxic, 
biologically inert byproducts. Polylactide polymers are being widely used for therapeutic 
applications due to their biocompatibility and biodegradation properties. The characterization of 
P2MS-57 polymer and polylactide polymers was performed by an undergraduate student, Olga 
Morozova, under my supervision. 
 
A.3 Experimental 
 
Cell Culture 
 RBL cells culture is previously described (Chapter 2). 
 
DNP-Polystyrene Synthesis and Characterization (Performed at CAU)  
Figure A.1 shows the generic structure of these polymers. They were synthesized using 
alpha-methyl styrene and 2-methoxystyrene as the base monomers and functionalized with DNP 
groups on both ends (Sannigrahi et al., 2008). DNP functionalized poly(2-methoxystyrene) was 
sulfonated in 1,2-dichloroethane at -10º C with acetyl sulfate, which was produced in situ by the 
reaction of acetic anhydride and sulfuric acid. Acetyl sulfate solution was prepared by mixing 
fixed amount of 1,2-dichloroethane with 1 ml (10.5 mmol) acetic anhydride. The solution was 
cooled to 00 C and 0.3 ml (5 mmol) 98% sulfuric acid was carefully added. During the 
preparation, an excess of acetic anhydride was used to remove any traces of water and the 
reaction mixture was stirred until a homogeneous and clear solution was obtained. The 
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sulfonation reaction was carried out by progressive addition of acetyl sulfate solution to 0.5 g (a 
5% w/w solution) poly (2-methoxystyrene) in 10 ml 1,2-dichloroethane at -10º C. The reaction 
continued until all the polymer was separated from solution and was terminated by adding few 
drops of 2-propanol. The insoluble polymer was washed thoroughly with 1,2-dichloroethane 
several times to remove access acetyl sulfate. Finally, polymer was dissolved in de-ionized water 
and titrated with 0.01 M NaOH solution to prepare Na-salt of sulfonated polymer. The titrated 
solution was washed with diethyl ether to remove phenolphthalein indicator and other small 
molecules. P2MS-xSO3Na-PEO was isolated by evaporating water under rotatory evaporator 
and azeotropic drying with toluene. The extent of sulfonation levels was also determined from 
the titration. The degree of sulfonation (x) expressed as mole percent of the sulfonated 2-
methoxystyrene repeating units, P2MS-xSO3Na-PEO was 67%. 
 
For characterization of these DNP-functionalized, sulfonated polymers, 1H NMR spectra 
were obtained using a Bruker ARX 400 NMR spectrometer in D2O, and trimethylsiloxane was 
used as internal standard. Spectra showed characteristic proton absorption of DNP at 8 ppm. By 
carrying out quantitative analysis of the NMR peaks, the degree of functionality was determined. 
Fourier transform infrared spectroscopy (FTIR) was also performed on the polymer samples and 
asymmetric and symmetric stretching for NO2 observed at 1536 cm-1 and 1351 cm-1, 
respectively. FTIR spectra were recorded on a Nicolet 510P FT-IR spectrometer with an 
accuracy band of ± 2 cm-1.  P2MS-SO3Na samples were measured as KBr pellets.  
 
For determination of molecular weights, size exclusion chromatography (SEC) was 
performed using a Perkin Elmer Binary LC pump 250, a 2792 injector and Perkin Elmer LC-30 
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RI detector. Three columns, HR3, HR 4E and HR 5E were used in conjunction with 2-µm pre-
column filter. The columns were housed in an oven maintained at 30ºC. Tetrahydrofuran was 
used as the eluent at a flow rate of 1 ml/ min. Molecular weights were calculated relative to 
polystyrene molecular weight standards (Aldrich).  
 
Differential scanning calorimetry measurements were performed on a Seiko DSC220 at a 
heating rate of 5˚C per minute, and the reported values were obtained from the second heating 
after quench-cooling the sample.  The glass transition temperatures (Tg) were taken at the 
midpoints of the heat capacity changes, the melting temperatures (Tm) were taken at the 
maximum of the enthalpy endothermic peaks.  
 
Binding study of polymers with anti-DNP FITC-IgE 
  To determine the binding affinity of these polymers with IgE antibody, fluorescence 
measurements were made using FITC-IgE as previously established (Erickson et al., 1986) in an 
SLM 8000 fluorimeter. The equilibrium binding equation to determine the fraction of bound sites 
is as follows: 
L = Free ligand concentration 
R = Free IgE binding sites 
Rtot = Total IgE binding sites (bound to ligand + free) 
Ka = Apparent association constant 
f = fraction of IgE binding sites occupied by the ligand at equilibrium 
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The fluorescence values obtained after addition of small aliquots of ligand were plotted against 
the ligand concentration after volume correction. The fraction of bound sites at varying ligand 
concentration was determined from these corrected fluorescence values (Erickson et al., 1986). 
The values obtained were fitted in the above hyperbolic equation using Sigma software to 
generate apparent association constant values (Ka). The inverse of Ka is defined as the apparent 
dissociation constant Kd.  
 
Granule exocytosis assay  
 For measuring the granule exocytosis response triggered by multivalent DNP-BSA or 
DNP-functionalized polymers, RBL cells were sensitized with 1 μg/ml anti-DNP IgE and plated 
overnight at a density of 2.5 x 105 cells in a 96-well plate under sterile conditions. These cells 
were incubated with DNP liganads  for 1 h at 37ºC, and the exocytotic release of the granule 
marker β-hexosaminidase was used to quantify the extent of degranulation as previously 
described (Naal et al., 2004).  
 
 To determine inhibition of degranulation, IgE-sensitized RBL cells were pre-incubated 
with varying concentrations of DNP-polymer for 30 minutes at 37˚C, followed by stimulation 
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with 2 ng/ml DNP-BSA for 30 minutes, also at 37˚C, and then β-hexosaminidase release was 
measured. 
 
Ca2+ measurement 
  Intracellular Ca2+ changes were measured in suspended cells loaded with indo-1 in a 
stirred cuvette using steady-state fluorimetry as described in Chapter 2. Cells were stimulated 
with 1 μM P2MS-57 followed by 0.2 μg/ml DNP-BSA. 
 
Microscopy visualized PKCβI-EGFP recruitment and IgE clustering 
 PKCβI-EGFP transfected cells, sensitized with IgE, were stimulated with 50 nM or 1 μM 
P2MS-57 for 5 minutes at 25˚C as described in Chapter 2 for DNP-BSA stimulation. 
 
IgE-FcεRI Clustering  
 RBL-2H3 cells plated in MatTek dishes were sensitized with Alexa488-conjugated IgE at 
a concentration of 3 μg/ml for 1 h at 37˚C. Labeled cells were incubated for 15 minutes at 37˚C 
with 50 nM or 1 μM P2MS-57 polymer in phosphate buffered saline with 1 mg/ml BSA (PBS-
BSA) and then fixed with 4% paraformaldehyde and 0.01% glutaraldehyde for 15 minutes at 
room temperature. Fixed cells were imaged with Leica TCS SP2 confocal microscope. 
 
Binding with electrospun polymers 
 BS 5-20 polymer [Table A.1] was electrospun in chlorobenzene with 1% single walled  
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Table A.1: Series of polystyrene polymers with varying molecular weights, % DNP 
functionality and apparent dissociation constants with RBL cells. Standard deviation for 
dissociation constants is from n = 2-3 for each polymer. DNP functionalization was 
determined from quantitative analysis of NMR spectra by CAU researchers. % DNP 
functionality is % of ideal two DNP groups per polymer. 
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carbon nanotubes on silicon wafer by researchers at CAU. We tested the specificity of these 
electrospun polymers towards IgE antibody by labeling the samples with FITC-IgE or FITC-IgG 
(for control) at a concentration of 3 μg/ml in PBS-BSA for 1 h at 37˚C. Samples were washed 
with PBS to remove unbound antibody and then imaged using confocal microcopy.  
 
A.4 Results 
 
 
 We have characterized a variety of polystyrene DNP-functionalized polymers (Figure 
A.1) for specific binding with anti-DNP IgE. We further evaluated their potential to stimulate or 
inhibit signaling events in mast cells. Researchers at CAU synthesized these DNP-functionalized 
polymers and determined their molecular weights and DNP percentage via spectroscopy, 
chromatography and calorimetry studies as described in the experimental section. These 
polymers vary in their molecular weight and DNP functionalization as summarized in Table A.1. 
 
 To test the specific binding of these polymers with anti-DNP IgE, we performed 
equilibrium titrations with RBL cells sensitized with FITC-IgE as previously described (Erickson 
et al., 1986). We determined the apparent dissociation binding constants (Kd) from these 
equilibrium binding studies by fitting the data to a simple binding equation described in the 
experimental section. As demonstrated in the representative binding curve in Figure A.2, the 
fraction of IgE-binding sites in solution vs. P2MS-57 polymer concentration resulted in a 
hyperbolic curve from which Kd was determined to be 178.3 + 97 nM (n = 4). We also 
determined the apparent dissociation constants for P2MS-57 polymer binding to IgE-FcεRI on 
cells as shown in Figure A.3. After this initial assessment of binding data, we focused our efforts 
on studying P2MS-57 polymer more extensively due to its high DNP functionality and its  
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Figure A.2: Representative binding curve for P2MS-57 polymer binding to 
soluble FITC-IgE from fluorescence quenching assay. 
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Figure A.3: Representative binding curve for P2MS-57 polymer binding 
to FITC-IgE bound to RBL-2H3 cells. 
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relatively tight binding affinity (Kd = 54.3 + 5.9 nM; n = 3). Dissociation constants for polymer 
binding to IgE on RBL cells summarized in Table A.1. 
  
 We also assessed the bivalent binding of these polymers by first determining the total 
available IgE binding sites with a monovalent ligand, DNP-aminocaproyl-L-tyrosine (DCT). As 
shown in Figure A.4, the initial data points were extrapolated to determine the total number of 
binding sites from DCT binding curve. We performed the binding experiment with the same 
sample of FITC-IgE sensitized cells with P2MS-57 polymer and found that the ratio of polymer 
per binding site is higher than 1, suggesting that these polymers are not binding bivalently and 
have some other complex binding mechanism. It is also possible that the binding conditions are 
not appropriate for determining available sites. 
 
 We examined the capacity of these DNP-functionalized polymers to trigger granule 
exocytosis in RBL cells. As shown in a single representative experiment in Figure A.5, we 
observed less than 1% granule exocytosis response as measured by β-hexosaminidase release 
from cells incubated with P2MS-57 polymer at varying concentrations, under similar conditions, 
multivalent DNP-BSA shows a granule exocytosis response of ~55%. P2MS-57 polymer was 
further tested for its capacity to inhibit granule exocytosis stimulated by multivalent antigen 
DNP-BSA. For investigating the inhibitory capacity of the polymer, we pre-incubated it with 
IgE-sensitized cells and then incubated with a sensitive concentration of DNP-BSA which was 
determined to be 2 ng/ml from Figure A.5. We found that the IC50 inhibitory concentration (i.e. 
50% inhibitory concentration of ligand) of P2MS-57 polymer is 4.5 + 2.1 μM (n = 4) as shown in 
Figure A.6. We tried to optimize the assay for determining the IC50 concentration by lowering 
the concentration of DNP-BSA used to 1 ng/ml and the time of incubation to 10 minutes. As  
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Figure A.4: Representative binding curve with DCT monovalent ligand 
binding to FITC-IgE bound to RBL-2H3 cells 
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Figure A.5: β-hexosaminidase release for monitoring granule 
exocytosis response in RBL cells upon incubation with P2MS-57 
polymer with varying concentrations (blue). Dose-response 
degranulation data with DNP-BSA to determine a sensitive 
concentration range for inhibition studies with polymers (red). 
Sensitive concentration (= 2 ng/ml) is circled in black. 
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Figure A.6: Inhibition of degranulation stimulated with 2 ng/ml DNP-BSA with 
P2MS-57 polymer. β-hexosaminidase release in the absence of inhibition was 
60%. 
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shown in Figure A.7, we observed an IC50 concentration of 2 μM for P2MS-57 polymer as 
compared to 4.5 μM obtained previously. 
 
 Since granule exocytosis requires Ca2+ mobilization and PKC activation, we evaluated 
the effect of P2MS-57 polymer in stimulating Ca2+ mobilization and PKC activation. As shown 
in Figure A.8, blue trace represents a standard antigen-stimulated Ca2+ response in RBL cells. 
We observed no Ca2+ mobilization in indo-1 loaded cells when an aliquot of 1 μM P2MS-57 
(final concentration in cell solution = 0.25 μM) was added to them (red trace) in Figure A.8. 
Addition of multivalent DNP-BSA to the same sample of cells gave a robust Ca2+ response, 
although the rate was delayed compared to the sample that contained no inhibitor. Also, we did 
not observe recruitment of PKCβI-EGFP to the plasma membrane as examined by confocal 
microscopy in Figure A.9. Our results, thus, strongly suggest that P2MS-57 do not stimulate 
normal signaling events in the mast cell signaling cascade at the concentrations that we 
evaluated. 
 
 We investigated whether P2MS-57 causes clustering of FcεRI-IgE on RBL cells, and 
observed no detectable patching of Alexa488-IgE upon incubation with P2MS-57 polymer as 
determined by confocal microscopy (Figure A.10), consistent with other results indicating that 
this polymer is not cross linking IgE-FcεRI at detectable levels at the concentrations we 
evaluated, and they did not trigger a detectable response in RBL cells.  
 
 We also characterized the binding and stimulated granule exocytosis capacity of a 
biodegradable polylactide polymer: polylactide 3 (Figure A.1) (molecular weight – 10.5 kDa; 
DNP functionality – 70%). Unlike the sulfonated polystyrene polymers (Figure A.1), polylactide  
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Figure A.7: Inhibition of degranulation with P2MS-57 polymer stimulated 
with 1 ng/ml DNP-BSA and incubated for 10 minutes (squares) or 30 
minutes (circles) with DNP-BSA. 
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Figure A.8: Ca2+ mobilization in response to DNP-BSA in RBL cells (blue). 
1 μM P2MS-57 addition showed no Ca2+ mobilization in cells (red), this was 
followed by 0.2 μg/ml DNP-BSA addition to get a robust response. 
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Figure A.9: Confocal images of PKCβI-EGFP 
transfected cells showing pre-stimulation (above) and 
post-stimulation (below) with P2MS-57 polymer (50 
nM) after 5 minutes.  
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Figure A.10: Confocal image of equatorial sections of Alexa-
488 IgE sensitized RBL cells without (above) and with (below) 
P2MS-57 polymer (50 nM) showing uniform distribution of IgE. 
Labeled cells were incubated for 15 minutes at 37˚C with 50 nM 
P2MS-57. 
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3 is insoluble in aqueous solution at 1 µM and hence we dissolved it in DMSO and used a final 
concentration of 2% DMSO v/v in the cell solution. Similar to the fluorescence quenching assay 
used for polystyrene polymers, we determined the Kd for polylactide 3 binding to IgE-FcεRI on 
cells to be 2.8 + 1.1 nM (n = 5) as shown in a representative binding curve in Figure A.11. 
Dissociation constant for polylactide 3 binding to IgE in solution was determined to be 4.2 + 1.8 
nM (n = 4). When compared to the dissociation constants for P2MS-57 polymer (54.3nM with 
IgE on cells and 178.3 nM with IgE in solution), we observe more than tenfold decrease in the 
Kd of polylactide 3 with IgE in solution as well as with IgE-FcεRI on cells, indicating that 
polylactide 3 binds much more tightly to IgE, most likely due to its smaller molecular weight and 
architecture. Under similar conditions, we also determined Kd with DCT ligand and found it to 
be 1.5 + 0.7 nM with IgE on cells and 4.6 + 1.0 nM with IgE in solution. 
 
 We found that polylactide 3 also did not trigger granule exocytosis in IgE-sensitized RBL 
cells similar to the polystyrene polymers under similar conditions. We were interested to assess 
the capacity of polylactide 3 to inhibit DNP-BSA stimulated granule exocytosis and determine 
its IC50 concentration. We tried multiple conditions by varying time of incubation with 1 ng/ml 
DNP-BSA (Figure A.12) and also variable concentrations of DNP-BSA (Figure A.13) to achieve 
the lowest IC50 concentration which was determined to be 50 nM with 1 ng/ml DNP-BSA 
stimulation for 10 minutes and 45 nM with 0.2 ng/ml DNP-BSA stimulation for 30 minutes. We 
also determined IC50 concentration for DCT under similar variable conditions of time of 
incubation with DNP-BSA and varying concentration of DNP-BSA (Figure A.14 and Figure 
A.15 respectively). We determined the lowest IC50 concentration with DCT to be 23 nM with 1 
ng/ml DNP-BSA stimulation for 10 minutes and 7 nM with 0.2 ng/ml DNP-BSA stimulation for 
30 minutes, indicating that DCT is still more potent in inhibiting degranulation as compared to  
 117 
 
Figure A.11: Representative binding curve for polylactide 3 polymer 
binding to FITC-IgE bound to RBL-2H3 cells. 
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Figure A.12: Inhibition of degranulation with polylactide 3 polymer 
stimulated with 1 ng/ml DNP-BSA and incubated for 10 minutes 
(squares) or 30 minutes (circles) with DNP-BSA gave IC50 values of 
50 nM and 69 nM respectively. 
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Figure A.13: Inhibition of degranulation with polylactide 3 polymer stimulated 
with 0.2 ng/ml, 1 ng/ml or 2 ng/ml for 30 minutes gave IC50 values of 45 nM, 70 
nM and 130 nM respectively. 
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Figure A.14: Inhibition of degranulation with DCT stimulated with 1 
ng/ml DNP-BSA and incubated for 10 minutes (squares) or 30 
minutes (circles) with DNP-BSA gave IC50 values of 23 nM and 52 
nM respectively. 
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Figure A.15: Inhibition of degranulation with DCT polymer stimulated with 
0.2 ng/ml, 1 ng/ml or 2 ng/ml DNP-BSA for 30 minutes gave IC50 values of 
7 nM, 53 nM and 70 nM respectively. 
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polylactide 3 polymer. The low aqueous solubility of polylactide 3 and 70% DNP content can 
account for the slightly higher IC50 of polylactide 3 as compared to DCT. It is also possible that 
polylactide 3 was degraded over time; the rate of degradation of this biodegradable polymer 
needs to be established to rule out this possibility. 
 
Another area of considerable interest is to utilize these polymers for biosensors by 
electrospinning them on single walled carbon nanotubes. These electrospun fibers have been 
found to be stable in aqueous solution, and it has been previously established that films of single 
walled carbon nanotubes mixed with CDNP-PEO-P2MS-PEO-CDNP are conductive as 
demonstrated by electrical conductivity measurements (data not published). We performed some 
preliminary experiments and found that BS 5-20 polymer electrospun on to silicon wafers could 
bind to anti-DNP FITC-IgE binding as shown in Figure A.16.  
 
A.5 Discussion 
 
 Polystyrene polymers functionalized by DNP and with enhanced solubility in water by 
incorporation of PEO and sulfonation (Figure A.1) were investigated for their binding properties 
and capacity to trigger or inhibit cellular signaling in mast cells. A biodegradable polylactide 
polymer, polylactide 3 (Figure A.1), was also characterized. We found that these polymers bind 
specifically to anti-DNP IgE immobilized on RBL cells; however, they did not elicit detectable 
signaling responses as determined by the lack of stimulated Ca2+ mobilization, PKC activation or 
granule exocytosis. 
 
 Since these polymers did not detectably crosslink IgE-FcεRI to initiate signaling even  
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Figure A.16:  Specificity of anti-DNP FITC-IgE binding with BS 
5-20 polymer electrospun on silicon wafers with 1% single walled 
carbon nanotubes (above). No binding was observed with 
nonspecific FITC-IgG (below).  
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though they demonstrated tight binding to IgE-FcεRI, this indicates that they are either binding 
bivalently intramolecularly or they are simply binding as monovalent ligands. To address the 
question regarding the bivalent binding of these polymers, we performed our binding studies in 
parallel with a monovalent ligand, DCT. With DCT binding studies, we had an approximate 
estimate of the IgE binding sites available and we then compared our polymer binding data with 
it to assess if these polymers are binding bivalently. Our data indicate that these polymers are not 
binding bivalently as determined by the ratio of polymer/binding site. However, the DNP 
functionality was not taken into account for determining the apparent dissociation constants or 
bivalency.  
 
 In the current study, we also found that both polystyrene and polylactide polymers can 
inhibit the granule exocytosis response stimulated by multivalent DNP-BSA. We observed an 
IC50 value of ~ 5 μM with P2MS-57 polymer in the presence of 2 ng/ml DNP-BSA. We were 
able to lower the IC50 value to 2 μM for this polymer by reducing the DNP-BSA concentration to 
1 ng/ml instead of 2 ng/ml and the time of incubation to 10 minutes instead of 30 minutes 
(Figure A.7). We were also able to lower the IC50 concentration of polylactide 3 to 45 - 50 nM 
after optimization of inhibition conditions as shown in Figure A.12 and A.13. However, under 
similar conditions, we found that the monovalent ligand DCT still has lower IC50 value 
indicating that it is still more potent in inhibiting granule exocytosis than these synthetic ligands.  
 
 In summary, we have established very good optimization conditions for characterizing 
the binding and inhibition capacity of DNP-functionalized polymers. Our data will provide good 
guidelines for assay of future DNP ligands to determine their potential in allergy therapeutics. 
Also, our preliminary data showing specificity of IgE towards these polystyrene polymers mixed 
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with single walled carbon nanotubes and electrospun on silicon substrate shows potential for 
their use in electrical and conductivity measurements for use in biosensors for detecting sensitive 
levels of IgE. 
 
 However, some key questions still need to be addressed to better understand the binding 
mechanism of these polymers with IgE in solution and IgE bound to RBL cells. Determining the 
length of each of these polymers by light scattering or by using a random walk model would help 
us correlate the dissociation constants with the size of each of these polymers. The distance 
between two IgE binding sites is about 10 nm (Baird et al., 1993). Polymers with an end to end 
distance close to 10 nm are expected to show intramolecular binding predominantly, and 
therefore have a higher potential for utility in allergy inhibition. For developing polymers in the 
future, it may be useful to synthesize lower molecular weight polymers with smaller size to 
achieve lower IC50 concentration. Enhancement of aqueous solubility of polylactide series of 
polymers and an evaluation their rate of degradation as a solid and in aqueous and organic 
solvents would also be helpful in obtaining a more accurate binding constant and inhibitory 
concentration. It would also be on great interest to visualize whether IgE-FcεRI is 
intermolecularly or intramolecularly crosslinked by these polymers by using super resolution 
microscopy techniques like STORM. To gain more insights in the inhibitory mechanism of 
granule exocytosis, we can test for upstream signaling steps like Lyn phosphorylation which can 
be tested by Western Blotting. Quantifying the percent inhibition of Ca2+ mobilization by DNP-
BSA in the presence of each of these polymers and correlating it with the percent inhibition in 
stimulated granule exocytosis would also help in further dissecting the mode of inhibition.  
 
 Electrospun fibers mixed with single walled carbon nanotubes need to be evaluated for 
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their capacity to show change in conductance before and after IgE binding before they can used 
for fabrication of an electro-conductive biosensor. Optimization of electrochemical 
measurements with these polymer fibers electrospun on silicon substrate is currently in progress 
by CAU researchers. 
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